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ABSTRACT 
 
 
DNA double strand breaks create a situation of extreme stress under which a cell 
must either be capable of repairing the lesions in order to continue replication or succumb 
to death. Not surprisingly, deficiencies in DNA repair genes often lead to human diseases 
frequently associated with genomic instability, cancer proneness, and neuropathology. 
Neurological consequences of aberrant DNA repair mechanisms vary depending upon the 
affected gene and the pathway in which it operates. Ataxia-telangiectasia (A-T) is the 
prototypical disease associated with DNA double strand break (DSB) repair deficiency 
and is characterized by severe neural pathology. A-T results from homozygous mutations 
that inactivate the ataxia-telangiectasia mutated (ATM) gene, and typically presents in 
early childhood as cerebellar ataxia accompanied by ocular telangiectasias, elevated !-
fetoprotein levels, and lymphoma predisposition compounded by radiosensitivity. The 
ATM protein is a large (~380 kDa) protein kinase within the PI3K family, which 
mediates cell cycle checkpoint activity and induces apoptosis through phosphorylation of 
copious substrates. It is thought to be through apoptotic induction of newly post-mitotic 
cells harboring lethal levels of DNA damage that Atm maintains integrity of the CNS, as 
it prevents incorporation of genomically compromised neurons into the mature nervous 
system. Hypomorphic mutations in the Mre11/Rad50/NBS1 complex (MRN complex), 
which is required for efficient ATM activity, result in distinct syndromes. Ataxia-
telangiectasia-like disease (ATLD) results from truncating mutations in Mre11 and 
presents with neurodegeneration similar to that observed in A-T, but with longer latency 
and less severity. Mutations in the FHA and BRCT domains of NBS1 result in Nijmegen 
Breakage Syndrome (NBS), which is characterized by microcephaly without evidence of 
neurodegeneration. Thus far mutations in Rad50 have not been reported in humans. 
  
In order to better understand the roles of ATM and MRN signaling in maintaining 
physical and functional integrity of the CNS, mutant mice either null for Atm or carrying 
hypomorphic mutations in Mre11 or Nbs1 were subjected to either endogenous or 
exogenous forms of DNA damage and the signaling response was assessed in the brain. 
To understand the contrasting neuropathology resulting from Mre11 or Nbs1 
hypomorphic mutations, we analyzed neural tissue from Mre11
ATLD1/ATLD1
 and Nbs1!
B/!B 
mice after genotoxic stress. We found a pronounced resistance to DNA damage-induced 
apoptosis after ionizing radiation or DNA ligase IV (Lig4) loss in the Mre11
ATLD1/ATLD1 
nervous system that was associated with defective Atm activation and phosphorylation of 
its substrate p53. Apoptosis occurred normally in the Nbs1
!B/!B
 brain. We also 
conditionally disrupted Lig4 throughout the nervous system using Nestin-cre (Lig4
Nes-Cre
), 
and while viable, these mice showed pronounced microcephaly and a prominent age-
related accumulation of DNA damage throughout the brain. Either Atm
-/-
 or 
Mre11
ATLD1/ATLD1
 genetic backgrounds, but not Nbs1
!B/!B
 rescued Lig4
Nes-Cre
 
microcephaly. Thus, DNA damage signaling in the nervous system is different between 
ATLD and NBS, and likely explains their respective neuropathology.  
 
Ataxia-telangiectasia and Rad3-related (ATR) is a large serine/threonine kinase 
that is highly similar in structure to ATM and phosphorylates many overlapping 
vi 
 
substrates. Hypomorphic mutations in ATR have been associated with some cases of 
Seckel syndrome, a microcephalic condition. Despite the similarities between ATM and 
ATR, inactivation of either kinase has quite distinct consequences. Unlike ATM, ATR is 
essential for embryonic development, as Atr
-/-
 embryos are lethal by E7.5. To better 
understand the differing roles of ATM and ATR in the nervous system, a conditional Atr 
mutant was crossed onto the Nestin-cre transgenic line. Atr
loxP/loxP
; Nestin-cre ( Atr
Nes-cre
) 
animals displayed early post-natal lethality and severe neurogenesis defects, particularly 
striking in the cerebellum due to decreased proliferation and viability of granule neuron 
progenitors. Surprisingly, progenitors in the rhombic lip were largely unaffected in Atr
Nes-
cre
 embryos whereas the granule cell precursors of the cerebellar external germinal layer 
(EGL) displayed DNA damage as early as E13.5 and p53-dependant apoptosis by E15.5. 
Between E15.5 and E16.5 p53 independent cell cycle arrest was inferred by decreased 
proliferation of the remaining granule cell precursors in the EGL. DNA damage was not 
observed in the rhombic lip until E16.5. The forebrain showed a similar pattern of 
acquired damage followed by apoptosis and decreased proliferation. The p53-null genetic 
background did not substantially rescue the Atr
Nes-cre
 phenotype despite blocking 
apoptosis. This data indicates that proliferation arrest is the major factor causing ATR-
Seckel syndrome and that ATR does not significantly contribute to p53-induced 
apoptosis in proliferating neural progenitors. Atr
Nes-cre
 animals were crossed onto an Atm 
conditional background (Atm
Nes-cre
) in order to assess how ATM and ATR cooperate in 
maintaining homeostasis in the brain. The Atm
Nes-cre
 background failed to alter the Atr
Nes-
cre
 phenotype, underscoring the divergence of ATR and ATM function during 
embryogenesis, despite overlapping substrates between the kinases.  
 
In summary, this work provides us with important insight into the requirements 
for specific DNA damage signaling molecules in the nervous system. ATM and ATR 
appear to have distinct roles in the nervous system with ATM required for elimination of 
compromised early post-mitotic neurons, while ATR is critical for maintaining integrity 
and replicative capacity of progenitor populations. Based upon this study, there is no 
obvious cross-talk or overlap between Atm and Atr signaling in the nervous system as 
each plays a separate role in different cell populations. Furthermore, we have begun to 
tease out the existence of independent signaling roles between Mre11 and Nbs1 in regard 
to Atm activity. While Mre11 mutations associated with ATLD compromise Atm-
dependant apoptosis, Nbs1 hypomorphism linked to NBS does not appear to negatively 
impact upon known Atm function in the nervous system. Overall these data provide new 
insights into the specific genetic requirements for DNA double strand break repair in the 
nervous system. 
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CHAPTER 1 INTRODUCTION! 
 
 
1.1 DNA Double Strand Break Repair 
 
 DNA double strand breaks (DSBs) are considered the most deleterious form of 
DNA damage. When left unrepaired, DSBs can cause apoptosis or the accumulation of 
genomic instability. DNA damage initiates complex signaling cascades that result in cell 
cycle checkpoint activation, DNA repair or apoptosis. Much of our understanding of 
these pathways comes from studies using patient-derived cell lines or mutant mice 
designed to model DNA repair deficits (Friedberg & Meira, 2006; Rosenthal & Brown, 
2007). ATM and ATR sit at the apex of DNA double strand break signaling, and are 
responsible for phosphorylating multiple substrates that impact cellular fate after damage. 
While ATM is predominantly activated by DSBs such as those produced by irradiation 
and subsequently initiates cell cycle checkpoints and/or apoptosis, ATR responds to 
agents that interfere with DNA replication (i.e., UV irradiation and hydroxyurea) and is 
essential to cellular viability (Brown & Baltimore, 2000; Cimprich & Cortez, 2008; 
Hurley & Bunz, 2007). The precise recruitment order of DNA damage signaling 
molecules to DSB sites is unclear, as the rapidity with which the damage response is 
activated makes delineating what comes first challenging. Phosphorylation of H2AX on 
the C-terminus Ser 139 is one of the earliest events occurring in response to DNA 
damage, and can be visualized immunohistochemically as distinct nuclear foci that mark 
DNA DSBs. A major function of "-H2AX is recruitment of other DNA damage response 
factors to the sites of DNA DSBs (Fernandez-Capetillo et al., 2004; Sedelnikova et al., 
2003). Though H2AX is not essential in the mouse, its loss predisposes to genomic 
instability (Celeste et al., 2003; Celeste et al., 2002). H2AX phosphorylation facilitates 
recruitment of MDC1 to the DNA break via binding to the "-H2AX C-terminus 
(Goldberg et al., 2003; Lou et al., 2003; Stewart et al., 2003). This interaction is required 
for signal amplification and effective modulation of downstream signaling (Bekker-
Jensen et al., 2005; Lou et al., 2006; Stucki et al., 2005; Stucki & Jackson, 2006).  
 
Two predominant pathways of DSB repair have been identified, nonhomologous 
end-joining (NHEJ) and homologous recombination (HR). These pathways are 
differentially required depending upon developmental stages and tissue type. A 
distinguishing characteristic between the DNA DSB pathways is the requirement of HR 
for a sister chromatid present in the S/G2 phase of the cell cycle. This implies that the 
repair of DSBs in non-replicating cells will occur via NHEJ, and it has been shown in the 
developing murine nervous system that abrogation of HR results in Atm-independent 
apoptosis in proliferating regions whereas loss of NHEJ repair leads to Atm-dependant 
apoptosis in post-mitotic areas (Gao et al., 2000; Lee et al., 2000; Orii et al., 2006). HR is 
an error-free process that uses a sister chromatid as template DNA to achieve precise 
repair (Helleday et al., 2007; Thacker & Zdzienicka, 2004; West, 2003). Homology-
                                                
* Adapted by permission from Phillips ER and McKinnon PJ (2007). Oncogene, 26, 
7799-808. 
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directed repair initially involves an Mre11-Rad50-Nbs1 (MRN)-mediated 5’-3’ resection 
followed by Rad51-mediated homology search and strand invasion. The Rad51 
recombinase complex functions in concert with a series of other factors including the 
Rad51 paralogs (Xrcc2, Xrcc3, RAD51L1, RAD51L2, RAD51L3), Rad52, and Rad54 
proteins during which the processed DNA strand invades the sister chromatid and 
initiates recombination (Helleday et al., 2007; Heyer et al., 2006; Thacker and 
Zdzienicka, 2004; West, 2003; Wyman et al., 2004). Strand invasion and migration 
involves formation of a structure termed a Holliday Junction, which is resolved via 
Rad54, Mus81/Emc1 and Rad51C/Xrcc3 following repair synthesis by DNA polymerase, 
thus completing the repair process. As would be surmised from the essential importance 
of homologous recombination during embryonic development, studies in the mouse 
indicate that many of the above factors are essential for survival and their inactivation 
leads to lethality (Friedberg & Meira, 2006). 
 
In contrast to HR, NHEJ is an error-prone mechanism that involves the DNA-
dependent protein kinase (DNA-PK) and the DNA ligaseIV (Lig4)-Xrcc4 complex that 
together facilitate re-joining of broken non-compatible DNA ends (Lieber et al., 2003). 
The DNA-PK complex contains the Ku70 and Ku80 proteins, which recognize the break 
and mediate recruitment of the DNA-PK catalytic subunit (DNA-PKcs) a 
serine/threonine kinase whose autophosphorylation and phosphorylation of other factors 
including H2AX is required for efficient NHEJ (Bassing & Alt, 2004; Burma & Chen, 
2004; Lees-Miller & Meek, 2003). Ligation of the DNA ends occurs via Lig4 in 
conjunction with its binding partner Xrcc4. An additional factor, Cernunnos/XLF, has 
been identified as a binding partner of the Lig4-Xrcc4 complex and appears to be 
necessary for efficient ligation via NHEJ (Ahnesorg et al., 2006; Buck et al., 2006). 
Subsets of NHEJ may involve other factors such as Artemis (Jeggo & O'Neill, 2002; 
Moshous et al., 2001). The extent to which Artemis is required during canonical NHEJ 
(independent of V(D)J recombination) remains uncertain, as conflicting data on its 
requirement for end-joining have been reported (Riballo et al., 2004; Rooney et al., 2003; 
Wang et al., 2005c; Zhang et al., 2004). However, DNA Ligase IV (Lig4) and Xrcc4 are 
essential for NHEJ and embryonic survival (Barnes et al., 1998; Frank et al., 1998; Gao 
et al., 1998), and their interaction is required for efficient end-joining as Lig4 alone is not 
sufficient to complete repair in the absence of Xrcc4 (Bassing & Alt, 2004; Critchlow et 
al., 1997; Grawunder et al., 1997; Grawunder et al., 1998a; Grawunder et al., 1998b). 
While HR is available for repair during late S phase, NHEJ is most prominently activated 
in G1, G0, and early S phase of the cell cycle (Rothkamm et al., 2003; Thacker & 
Zdzienicka, 2004). However, animal studies indicate that there is cooperativity between 
these pathways during development (Couedel et al., 2004; Mills et al., 2004). 
 
While NHEJ requires DNA-PK and Lig4-Xrcc4, studies suggest that there may be 
an NHEJ repair pathway that utilizes other components, and in some cases can occur 
without DNA-PK (DiBiase et al., 2000; Perrault et al., 2004). For instance DNA ligase III 
(Lig3) has been implicated as an alternate ligase that may function in NHEJ (Wang et al., 
2005; Windhofer et al., 2007). In vitro evidence implicating PARP-1 and Xrcc1/Lig3 in 
NHEJ has also been obtained through end-joining assays (Audebert et al., 2004). The 
physiologic relevance of such phenomena remains unclear though, as no substantial 
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compensatory mechanisms appear in either Xrcc4-deficient or Lig4-deficient mice. If 
Lig3 does compensate in vivo, it does so only partially and is insufficient for normal 
mammalian development in the absence of Lig4.  
 
The requirement for efficient DNA repair mechanisms is underscored by the severe 
consequences observed in individuals lacking full activity of signaling factors or repair 
genes. Human deficiencies in ATM, ATR, MRN, or Lig4 (to list only a few) have been 
identified and present with neuropathology, immunodeficiency, and chromosomal 
instability. Though many characteristics of such genetic aberrations overlap, there are 
also distinctions indicative of differing specific functions. 
 
 
1.2 Consequence of DSB Repair Deficiencies in Humans 
 
1.2.1 Ataxia-telangiectasia, mutated (ATM) 
 
The canonical example of DNA DSB sensitivity in humans is the 
neurodegenerative syndrome, ataxia-telangiectasia (A-T). This disease is characterized by 
pronounced cerebellar ataxia attributed to Purkinje cell (PC) degeneration, ocular 
telangiectasia, lymphoma, sterility, immunodeficiency, dysarthria and radiosensitivity 
(Chun & Gatti, 2004; McKinnon, 2004). A-T results from null mutations in the gene 
ATM (ataxia-telangiectasia, mutated) (Savitsky et al., 1995). ATM is a serine/threonine 
kinase that modulates many substrates critical to the DNA damage response (Bakkenist & 
Kastan, 2004; Shiloh, 2003; Shiloh, 2006). Tissue specificity is an important aspect of 
ATM function, and relates to the pleiotropic nature of A-T. For instance, some ATM 
deficient tissues are extremely radiosensitive such as the intestine or hematopoietic 
system, while in contrast ATM-deficient immature neurons are radioresistant (Frappart & 
McKinnon, 2006).  
 
Activation of ATM in response to DNA damage involves autophosphorylation, 
which converts ATM from an inactive dimer to an active monomer (Bakkenist & Kastan, 
2003). ATM autophosphorylation sites have been identified on serines 1981, 1893 and 
367. Transfection of A-T cells with cDNAs containing mutations of these sites results in 
aberrant kinetics of p53 and Chk2 phosphorylation, suggesting each site contributes to 
ATM activity (Bakkenist & Kastan, 2003; Kozlov et al., 2006). However, the in vivo 
significance of such events remains unclear. Transgenic mice expressing an S1987A 
mutated BAC were crossed onto an Atm
-/-
 background and found to be indistinguishable 
from Atm
+/-
 mice, as growth retardation, genomic instability, lymphocyte development, 
and ATM-dependent phosphorylation of Chk2, SMC1, and p53 were restored in 
Atm
TgS1987A
Atm
-/-
 mice (Pellegrini et al., 2006). A transgenic mouse model in which all 
three currently known autophosphorylation sites were inactivated was recently reported. 
Atm-dependent DNA damage responses were normal in these mice. Thus, while 
phosphorylation of these sites is indicative of ATM activation, they do not appear to be 
required for ATM signaling itself (Daniel et al., 2008). 
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An important issue is precisely how DNA DSBs signal to ATM. This occurs via 
the MRN complex. MRN-deficient cells show abrogated ATM autophosphorylation and 
impaired phosphorylation of p53, Chk2, and Smc1 concomitant with suppression of the 
ATM-dependent G2/M checkpoint (Carson et al., 2003; Difilippantonio et al., 2005; 
Uziel et al., 2003). These studies implicate the MRN complex as the primary sensor of 
DNA damage and place it upstream of ATM activation. Mechanistically, MRN-
dependent ATM activation at DNA breaks has been reported to require interaction 
between ATM HEAT repeats and the C-terminal FXF/Y domain of Nbs1 (Falck et al., 
2005; You et al., 2005). The in vivo significance of this requires further study as while 
the NBS1 C-terminal mutant mice show apoptotic defects in the thymus, ATM functions 
were at least partially intact suggesting that interaction with the NBS1 C-terminus is 
dispensable for most ATM activity (Difilippantonio et al., 2007; Stracker et al., 2007). 
 
In response to DNA damage, ATM phosphorylates p53 on serine 15 and other 
sites thereby directly mediating its activation and stabilization (Lavin & Kozlov, 2007; 
Lukas et al., 2004). ATM-dependent phosphorylation activates Chk2, which blocks DNA 
replication via enhanced p53 activation and Cdc25A degradation (Falck et al., 2002). 
ATM indirectly affects p53 stabilization through down-regulation of its ubiquitin ligase 
Mdm2 (Khosravi et al., 1999; Maya et al., 2001). COP1 is yet another E3 ligase of p53 
that ATM phosphorylates, resulting in its degradation and subsequent p53 stabilization 
(Dornan et al., 2006). These ATM-dependent modifications collectively function to affect 
p53-dependent cell cycle arrest or apoptosis. 
 
In addition to directly regulating cell cycle checkpoints, apoptosis, and DNA 
repair, ATM has also been implicated in mediating DNA damage-induced chromatin 
modification. Treatment of primary human fibroblasts with chromatin modifying agents 
(chloroquine or HDAC inhibitors) induced ATM activation without forming obvious 
DNA DSBs, suggesting that direct DNA damage is not the only activator of ATM 
signaling (Bakkenist & Kastan, 2003). Identification of ATM-dependent, DNA damage-
induced chromatin relaxation via KAP-1 activity has further demonstrated the 
dependence of DNA repair on alteration of chromatin structure. ATM phosphorylates 
KAP-1 on Ser 824, and ablation of this site was demonstrated to abolish DSB-induced 
chromatin relaxation and resulted in cellular hypersensitivity to DSB-inducing agents 
(Ziv et al., 2006). Moreover, ATM has also been implicated in regulating ordered 
chromatin changes after DNA breaks to facilitate DNA repair (Berkovich et al., 2007). In 
essence ATM targets a vast array of substrates, which likely account for the pleiotropic 
nature of A-T. 
 
 
1.2.2 Ataxia-telangiectasia and Rad3-related (ATR) 
 
Mutations in the other major DNA repair kinase, ataxia-telangiectasia and Rad3 
related (ATR), have been attributed to the microcephalic condition Seckel syndrome. 
While ATM responds to DSBs (such as induced by IR) through Chk2 activation, ATR 
targets Chk1 in response to DNA replication stress, and activates the intra-S phase 
checkpoint (Conti et al., 2007). Seckel syndrome is inherited autosomal recessively and 
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characterized by microcephaly, intrauterine growth defects, dwarfism, and mild mental 
retardation (OMIM #210600). In some affected individuals, hypomorphic splicing 
mutations in ATR have been identified as the disease causation (O'Driscoll et al., 2004; 
O'Driscoll et al., 2003a; O'Driscoll et al., 2003b). While there is reported cross-talk 
between ATM and ATR (Jazayeri et al., 2006; Matsuoka et al., 2007; Yoo et al., 2007), 
they have separable biochemical roles and complete ATR loss is incompatible with 
viability. Atr
-/-
 embryos die between the blastocyst stage and E7.5. Isolation of Atr
-/-
 
embryos at day 3.5 revealed that blastocysts hatched normally from the zona pellucida 
and implanted onto tissue culture plastic after 1 day in culture, but failed to expand 
beyond 2 days in culture and died by culture day 4 due to accumulation of caspase 3-
independent DNA fragmentation and consequent apoptosis (Brown & Baltimore, 2000). 
Despite structural similarity and overlapping substrates between ATR and ATM, there is 
unlikely to be significant redundancy in their roles during neurogenesis. Other 
microcephalic diseases associated with DSBR deficiency include LIG4 syndrome, 
Nijmegen breakage syndrome, and possibly primary microcephaly due to the recently 
described microcephalin gene (MCPH). 
 
 
1.2.3 DNA ligase IV (Lig4) 
 
Human deficiency in DNA ligase IV causes microcephaly, developmental delay, 
radiosensitivity and immunodeficiency (O'Driscoll et al., 2001). LIG4 syndrome was first 
identified in a radiosensitive leukemia patient carrying a missense mutation (R278H) that 
conferred decreased ligation capacity (Riballo et al., 1999). This mutation was 
subsequently shown to decrease LIG4 adenylation and ligation activity by about 10% 
(O'Driscoll et al., 2001; Riballo et al., 1999; Riballo et al., 2001). Additional LIG4 
syndrome individuals have since been identified with variable phenotypic penetrance 
dependant upon the particular hypomorphic mutations expressed. For instance, an 
individual with an R278H mutation in addition to the N-terminal polymorphisms A3V 
and T9I presented with microcephaly, pancytopenia, and developmental delay (Girard et 
al., 2004; O'Driscoll et al., 2001). In vitro studies revealed no residual LIG4 adenylation 
or ligation activity in the 411BR mutation (Girard et al., 2004). Two siblings who 
presented with SCID, growth defects, and microcephaly were found to have compound 
heterozygous mutations conferring a Q280R substitution on one allele and a K424 frame-
shift mutation, resulting in truncation of the C-terminus on the other allele (Buck et al., 
2006b). Given the lethality of mice with inactivated Lig4 the hypomorphic mutations 
present in the human syndrome suggests that loss of LIG4 would not be compatible with 
viability, and that even attenuated activity has a substantial developmental effect.  
 
 
1.2.4 The Mre11/Rad50/Nbs1 complex (MRN) 
 
While no human deficiency has been reported for Rad50, hypomorphic mutations 
in Mre11 and Nbs1 cause ataxia-telangiectasia like disease (ATLD) and Nijmegen 
breakage syndrome (NBS), respectively (Stewart et al., 1999; Varon et al., 1998). ATLD 
presents with cerebellar ataxia similar that seen in A-T, but less severe and with a longer 
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latency, whereas NBS is characterized by microcephaly without neurodegeneration. 
Overlapping features of ATLD, A-T, and NBS include immunodeficiency, chromosomal 
instability, and reproductive defects (Pitts et al., 2001; Stewart et al., 1999; Varon et al., 
1998). Given the differing neurologic phenotypes of A-T, ATLD, and NBS, despite 
overlapping features outside the brain, it is reasonable to suspect that there is tissue-
specificity to Nbs1 function. Figure 1.1 summarizes the relationships between A-T, 
ATLD, NBS, ATR-SS, and LIG4 syndrome. 
 
 
1.2.5 Mouse models of DNA repair deficiencies 
 
Atm null mice have provided much insight into the nature of A-T by 
recapitulating many features of the disease, including growth retardation, 
immunodeficiency, sterility, and thymic lymphoma. However, no overt 
neurodegeneration has been observed in Atm
-/-
 mice, thus impeding comprehension of 
how and why cerebellar degeneration occurs in A-T individuals (Barlow et al., 1996a; 
Elson et al., 1996b; Herzog et al., 1998; Xu et al., 1996a). Human A-T derived cell lines 
and mouse Atm-null cells display similar phenotypes including premature senescence, 
radiation sensitivity, decreased p53 induction and cell cycle checkpoint defects (Barlow 
et al., 1996a; Xu & Baltimore, 1996; Xu et al., 1998).  
 
Irradiation studies in the developing Atm-null NS showed that ATM regulates 
p53-dependent apoptosis of newly post-mitotic neurons, implying that it functions as a 
clearance mechanism of irreparably damaged cells during development. Post-mitotic 
neurons of the developing CNS and the dorsal root ganglia of postnatal Atm
-/-
 mice were 
resistant to irradiation-induced apoptosis in comparison to wild-type animals. Consistent 
with the lack of apoptosis, p53 stabilization was drastically attenuated in the 
radioresistant Atm
-/-
 tissues and there was a similar lack of IR-induced neural apoptosis in 
p53-null animals (Chong et al., 2000; Herzog et al., 1998; Lee et al., 2001). Chk2, Puma, 
and Bax deficiencies have also been shown to abrogate IR-induced apoptosis in the 
developing nervous system (Chong et al., 2000; Jeffers et al., 2003; Takai et al., 2002). 
 
The Mre11
ATLD1/ATLD1
 mouse model harboring a hypomorphic mutation designed 
to mimic mutations found in ATLD patients showed chromosomal instability and 
checkpoint defects in primary cell cultures, and Mre11
ATLD1/ATLD1
 females failed to 
produce offspring due to reduced embryonic viability (Theunissen et al., 2003). Likewise, 
the nibrin hypomorph Nbs1
"B/"B
 mouse model did not recapitulate microcephaly as seen 
in NBS individuals, but did show a cellular phenotype identical to that of primary 
cultures derived from NBS patients including intra-S phase checkpoint defects, 
chromosomal instability, and radiosensitivity (Williams et al., 2002). Additionally, the 
NBS1
m/m
 mouse model displayed lymphoma predisposition and infertility, as did the 
humanized mouse model hNbs1
657"5
 (Difilippantonio et al., 2005; Kang et al., 2002). 
Further understanding of NBS neuropathology came with the conditional Nbs1 knockout 
model, Nbn
f6/f6
. On a Nestin-cre background, this mouse model demonstrated 
microcephaly and severe developmental defects of the cerebellum, associated with 
decreased proliferation of granule cell progenitors and increased apoptosis of inner 
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Figure 1.1 Diseases associated with DNA double-strand break repair deficits.  
Ataxia-telangiectasia mutated (ATM) deficiency results in a pleiotropic phenotype, the 
most debilitating feature of which is progressive neurodegeneration. MRE11 mutations 
are associated with A-T-like disease (ATLD), which mimics the neurodegenerative 
aspect of A-T. Though NBS1 acts with MRE11 to regulate ATM activation, NBS1 
hypomorphic mutations are associated with microcephaly, not neurodegeneration. The 
Nijmegen breakage syndrome (NBS) phenotype overlaps with ATM and rad3-related 
(ATR) deficiency more so than with A-T. Mutation of LIG4 is also associated with 
microcephaly and resembles NBS and ATR-Seckel syndrome.  
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external granule layer (EGL) cell populations (Frappart et al., 2005). While the Nbn
f6/f6
 
model provides insight into how DNA repair deficiency can affect the developing 
nervous system, the reason for reliance of the mature CNS upon ATM function remains 
obscure. Rescue of Lig4-mediated apoptosis by Atm-deficiency demonstrated the 
requirement for ATM-dependent apoptosis during neural development to maintain 
genomic integrity of cells incorporated into the mature nervous system (Lee et al., 2000; 
Sekiguchi et al., 2001). Accordingly, p53 deficiency rescued Xrcc4/Lig4-mediated 
apoptosis as well (Frank et al., 2000). Interestingly, Lig4
-/-
p53
-/-
 mice survived into 
adulthood and developed pro-B cell lymphomas or medulloblastomas (Frank et al., 2000; 
Lee & McKinnon, 2002), whereas Lig4
-/-
Atm
-/-
 animals died perinatally (Lee et al., 2000; 
Sekiguchi et al., 2001). These studies suggest that ATM deficiency allows cells carrying 
a genotoxic level of DSBs to be incorporated into the nervous system, and eventually 
such neurons would succumb to apoptosis or some other form of death resulting in 
neurodegeneration (Lee & McKinnon, 2007). Furthermore, these studies indicate a 
developmental role of ATM in addition to mediation of p53-dependent apoptosis that are 
vital in responding to DNA damage. Table 1.1 summarizes relevant mouse models and 
the degree to which their respective diseases are phenocopied.  
 
The DNA DSB response is required for development and maintenance of tissue 
homeostasis. The DNA damage response is also a barrier to transformation, and if 
inactive in the face of replication stress, cellular transformation can occur (Bartkova et 
al., 2005; Bartkova et al., 2006; Di Micco et al., 2006). Multiple human syndromes result 
from the mutation of genes required for the response to DNA DSBs. In many cases these 
syndromes feature defective developmental processes, including microcephaly, 
neurodegeneration, immunodeficiency, and growth retardation. Delineating the 
underlying molecular defects in these diseases promises to uncover further important 
details about DNA DSB repair (Phillips & McKinnon, 2007).  
 
The molecular mechanisms responsible for the distinct neuropathologies observed 
in ATLD and NBS are of particular interest, as Mre11 and Nbs1 are both implicated in 
ATM activation, coordination of the DSB response, and maintaining the integrity of 
cellular proliferation during early mammalian development. The fact that hypomorphic 
mutations in Mre11 cause neurodegeneration while Nbs1 mutations have been associated 
with microcephaly suggests that different downstream signaling events occur in ATLD 
and NBS. In Chapter 2 of this work, mouse models for ATLD and NBS were used to 
evaluate the consequences of hypomorphic mutations in either Mre11 or Nbs1 in the 
nervous system, as pertaining to DSB signaling. Similar to NBS, ATR-Seckel syndrome 
is associated with developmental delay and microcephaly. ATM and ATR are very 
similar kinases that mediate the DNA DSB response, but human deficits in these proteins 
result in very different consequences. To better understand the relationship between ATM 
and ATR signaling in the nervous system, a conditional Atr knock-out mouse model was 
used to specifically evaluate how Atr functions in the nervous system to ensure 
developmental integrity. Double conditional Atr, Atm mutant mice were generated to 
assess how Atm and Atr cooperate in development and maintenance of the CNS. The 
work presented in this dissertation has provided valuable new insights into the signaling 
pathways that prevent neuropathology associated with DNA damage. 
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Table 1.1 Phenotypes resulting from inactivation of murine DNA damage response 
genes. 
 
Gene Mouse Model Mouse Phenotype Human 
Disease 
Human Phenotype 
ATM Atm
-/-
 
(Barlow et al., 
1996b; Elson et 
al., 1996a; Xu et 
al., 1996b) 
Thymoma 
predisposition, 
sterility, 
radiosensitivity 
Ataxia-
telangiectasia 
Cerebellar ataxia, 
ocular telangiectasia, 
thymoma, sterility, 
genomic instability, 
radiosensitivity 
NBS1
m/m
 
(Kang et al., 
2002) 
 
Thymoma 
predisposition, 
sterility, 
radiosensitivity 
Nbn
f6/f6
; nestin-
Cre 
(Frappart et al., 
2005) 
Microcephaly, 
ataxia, cerebellar 
development defects 
NBS1
-/-
 
(Zhu et al., 2001) 
Embryonic lethality 
(~E7.5) 
NBS1
"B/"B 
(Williams et al., 
2002) 
Cell cycle 
checkpoint defect in 
MEFs, synthetic 
lethal with Atm
-/- 
NBS 
hNbs1
657"5
 
(Difilippantonio 
et al., 2005) 
Impaired 
development, 
lymphoma 
Nijmegen 
breakage 
syndrome 
Microcephaly, 
growth retardation, 
immunodeficiency, 
characteristic facial 
features, lymphoma 
MRE11 Mre11
ATLD1/ATLD1
 
(Theunissen et al., 
2003) 
Cell cycle 
checkpoint defect in 
MEFs, synthetic 
lethal with Atm
-/- 
Ataxia-
telangiectasia 
like disease 
Cerebellar ataxia, 
genomic instability 
DNA 
Ligase IV 
Lig4
-/-
 
(Barnes et al., 
1998; Frank et al., 
1998) 
Embryonic lethality 
(~E16.5), neuraxis 
wide apoptosis, 
immunodeficiency 
LIG4 
syndrome 
Microcephaly, 
characteristic facial 
features, 
immunodeficiency, 
radiosensitivity, 
growth retardation 
Lig4
Y288C
 
hypomorph 
(Nijnik et al., 
2007) 
Growth retardation, 
immunodeficiency, 
hematopoietic stem 
cell deficiency 
 
ATR 
Atr
-/-
 
(Brown & 
Baltimore, 2000) 
Embryonic lethality 
(before E7.5) 
 
Seckel 
syndrome 
 
Microcephaly, 
characteristic facial 
features, 
chromosomal 
instability 
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CHAPTER 2 DIFFERENTIAL DNA DAMAGE 
SIGNALING ACCOUNTS FOR DISTINCT 
NEUROPATHOLOGY ASSOCIATED WITH ATLD 
AND NBS! 
 
 
2.1 Introduction 
 
The developing nervous system is highly susceptible to DNA damage, and many 
human syndromes caused by DNA repair deficiency present with pronounced 
neuropathology (Katyal & McKinnon, 2007; McKinnon & Caldecott, 2007; Rass et al., 
2007). Within the developing nervous system, DNA DSBs pose a significant threat and 
are normally repaired by either non-homologous end joining (NHEJ) or homologous 
recombination (HR) (Lees-Miller & Meek, 2003; Lieber et al., 2003; West, 2003). 
Coincident with repair, DNA DSBs also activate cell cycle checkpoints to pause cellular 
proliferation and ensure fidelity of repair and the maintenance of genomic integrity 
(Kastan & Bartek, 2004; Shiloh, 2006; Zhao et al., 2000). An alternative outcome from 
DNA DSBs, and one that is frequent during neural development is the activation of 
apoptosis to eliminate DNA-damaged cells (Difilippantonio et al., 2007). 
 
Mre11/Rad50/NBS1 (MRN) and ATM (ataxia telangiectasia, mutated) are 
required to coordinate the DNA DSB signaling response (Kastan & Bartek, 2004; Lavin 
& Kozlov, 2007; Petrini & Stracker, 2003; Shiloh, 2006). The MRN complex rapidly 
localizes to DNA DSBs, where it recruits and activates the ATM kinase to initiate DNA 
damage signaling (Carson et al., 2003; Lee & Paull, 2004; Uziel et al., 2003). ATM 
initiates a signaling cascade via phosphorylation of multiple substrates resulting in cell 
cycle checkpoints or apoptosis (Uziel et al., 2003). In the nervous system p53 and Chk2 
are particularly important (Lee et al., 2001; Takai et al., 2002). MRN modulation of ATM 
activation requires protein-protein interactions with the NBS1 C-terminus (Falck et al., 
2005), although the ATM-MRN interplay is complex and likely to involve multiple 
protein interactions in determining the outcome of DNA DSB signaling (Difilippantonio 
et al., 2007; Stracker et al., 2007). 
 
Underscoring the importance of the DSB response is the occurrence of diseases 
when mutations render ATM, Mre11 or NBS-1 dysfunctional and result in ataxia 
telangiectasia (A-T), A-T-like disease (ATLD) or Nijmegen breakage syndrome (NBS) 
respectively (Kobayashi et al., 2004; McKinnon, 2004; Taylor et al., 2004). Unlike ATM, 
MRE11 and NBS1 are essential during development (Xiao & Weaver, 1997; Zhu et al., 
2001), thus syndromes involving these genes result from hypomorphic mutations. A-T is 
primarily characterized by cerebellar ataxia associated with Purkinje cell degeneration  
                                                
!
Adapted with permission from Shull ERP, Lee Y, Nakane H, Stracker TH, Zhao J, 
Russell HR, Petrini JHJ, and McKinnon PJ. (2009). Genes Dev, 23(2) 171-180. 
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(McKinnon, 2004). Other phenotypic characteristics of A-T are immunodeficiency, 
radiosensitivity, ocular telangiectasia, sterility and cancer predisposition. ATLD is also 
characterized by neurodegeneration and radiosensitivity (Taylor et al., 2004). In contrast, 
NBS features microcephaly, immunodeficiency, radiosensitivity, and cancer 
predisposition (Kobayashi et al., 2004). The overlapping phenotypes of A-T, ATLD, and 
NBS presumably reflect important functional interactions between ATM and the MRN 
complex. However, the distinct neuropathology present in ATLD compared to NBS 
indicates that the hypomorphic MRN mutations that give rise to these diseases must 
ultimately lead to different downstream signaling events to account for the distinct 
neuropathology. How this occurs is unknown. 
 
Using mouse models for ATLD and NBS, an in vivo analysis of the functional 
consequence of these hypomorphic mutations in the nervous system was performed. 
Exogenous and endogenous genotoxic stress was induced to evaluate the relative roles of 
ATM, Mre11 and Nbs1 during neural development and to investigate the signaling 
defects that could account for the distinct neuropathology characteristic of each disease. 
Our data show that the disease-causing mutations in MRN lead to defects in DNA 
damage-induced signal transduction in the nervous system, whereby the relative 
activation of apoptosis may underpin the differential neuropathology of these syndromes. 
 
 
2.2 Experimental Procedures 
 
 
2.2.1 Animals 
 
To generate a conditional DNA Ligase IV allele, Dr. Helen Russell obtained a 
murine BAC genomic clone (strain, 129Ola) containing an ~13kb BamHI fragment with 
the Lig4 genomic locus, into which she placed a LoxP sequence into a unique MluI site 
4.8kb upstream of the Lig4 ORF and a floxed NeoTK construct cloned as a HindIII 
fragment ~1.7kb downstream to generate pLig4
LoxP
. ES cells (W9.5; 129S1/SvImJ) were 
electroporated with linearized pLig4
LoxP
 and selected with G418 antibiotic and correctly 
targeted cells were identified by Southern Blot analysis. Targeted ES clones were then 
electroporated with pMC-cre, followed by selection in FIAU (5-iodo-2'-fluoro-2'deoxy-1-
arabinofuranosyluracil) to kill cells containing TK. ES cells were then injected into 
blastocysts and the resultant chimeric mice assessed for germline transmission of the 
floxed Lig4 allele (St. Jude Children’s Research Hospital Transgenic Core). Nestin-cre 
mice (B6.Cg-Tg(Nes-cre)1Kln/J; JAX #003771) were used to delete Lig4 throughout the 
nervous system. 
 
Animals were housed in an Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC)-accredited facility and were maintained in 
accordance with the NIH Guide for the Care and Use of Laboratory Animals. The St. 
Jude Children’s Research Hospital IACUC approved all procedures for animal use. 
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2.2.2 Histology and immunohistochemistry 
 
Mice were sacrificed via transcardial perfusion using 4% paraformaldehyde 
(PFA). Tissues were further fixed in 4% PFA overnight, and either cryoprotected in 25% 
PBS-buffered sucrose solution and embedded in O.C.T. (Tissue-Tek) or paraffin-
embedded. Frozen tissue was sectioned at 10 µm thickness using a Microm HM500 M 
cryostat. Paraffin-embedded spinal cord samples were sectioned at 40 µm thickness using 
a Microm HM 325.  
 
Antigen retrieval was used for all immunohistochemistry using the anti-phospho-
"H2AX (1:500; Abcam), anti-53BP1 polyclonal (1:500; Bethyl laboratories), anti-p53 
(CM5; 1:500; Vector Laboratories); anti-p53 phospho-Ser-15 (1:500; Cell Signaling), and 
anti-active caspase 3 (1:500; BD Biosciences) antibodies. For immunofluorescent 
staining, sections were subsequently immunolabelled with Cy3-conjugated goat anti-
mouse (1:400; Jackson Immunoresearch) and/or FITC-conjugated goat anti-rabbit 
secondary antibodies (1:500; Jackson Immunoresearch) and mounted with Vectashield 
anti-fade reagent containing DAPI (Vectorlabs). Immunohistochemistry for activated 
caspase-3 or p53-ser15 was performed overnight at room temperature after quenching 
endogenous peroxidase activity with 0.6% hydrogen peroxide in methanol. 
Immunoreactivity was visualized with a vasoactive intestinal peptide substrate kit (V.I.P.; 
Vector Labs) according to the manufacturer's directions after tissues were treated with 
biotinylated secondary antibody and avidin DH-biotinylated horseradish peroxidase-H 
complex (Vectastain Elite kit; Vector Labs). Sections were counterstained with 0.1% 
methyl green (Vector Labs), dehydrated, and mounted in DPX reagent. Apoptotic cells 
were detected with ApopTag Fluorescein in situ apoptosis detection kit (Chemicon 
international) according to the manufacturer’s instructions. "H2AX and 53BP1 foci were 
quantitated manually under the microscope at 400x magnification. Quantitation of 
TUNEL or caspase-3 positive cells was determined by counting positive signal from 
images equivalent in size and magnification between genotypes. Images were captured 
using an Axioskop 2.0 microscope (Carl Zeiss) and a SPOT camera (Diagnostic 
Instruments, Inc).  
 
 
2.2.3 Astrocyte culture 
 
Cerebral cortices were isolated from P4 mice and placed into a 35 mm dish 
containing ice cold 1:1 mix of Dulbecco’s modified Eagle’s medium and Ham’s nutrient 
mixture F-12 (DMEM-F12; Gibco) supplemented with 2 mM L-glutamine, 100 U/mL 
penicillin, and 100 µg/mL streptomycin. Meninges were removed under a dissecting 
microscope and cortices were transferred to a new dish containing fresh media mix as 
described above. Cortices were dissociated by passage through a 5mL pipette, then 
centrifuged at 1000 rpm for 5 min. Cells were resuspended in DMEM-F12 supplemented 
with 10% fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL 
streptomycin, and 20 #g/mL epidermal growth factor (Sigma). Astrocytes were allowed 
to establish in Primeria T-25 tissue culture flasks (Falcon) at 37°C in a humidified 
incubator. Medium was refreshed after 4 days in culture and cells were trypsinized at 
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100% confluence (typically ~1 week post-isolation). Cells were seeded onto 4-chambered 
poly-D-lysine coated slides (Falcon) at 2x10
4
 cells/chamber and allowed to establish for 2 
days prior to treatment and staining. 
  
Cells were irradiated using a Gammacell® 40 Exactor (MDS Nordion). Following 
irradiation, slides were returned to incubator. After the designated recovery time, cells 
were washed in PBS for 5 min at RT, then fixed in 3% PFA/ 0.2% triton-X100 for 15 min 
at 4 °C. Blocking solution (1.5% milk in PBS) was applied for 1 hr at RT, followed by 
incubation with anti-phospho-"H2AX (1:1000; Abcam) overnight at 4 °C. Primary 
antibody solution was aspirated from slide chambers, and cells were washed in PBS. 
Cells were subsequently immunolabelled with FITC-conjugated goat anti-rabbit 
secondary antibodies (1:500; Jackson Immunoresearch) and mounted with Vectashield 
anti-fade reagent containing DAPI (Vectorlabs). Images were captured at 400x 
magnification using an Axioskop 2.0 microscope (Carl Zeiss) and a SPOT camera 
(Diagnostic Instruments, Inc). Quantitation of foci was performed using the Adobe® 
Photoshop® plugin Image Processing Tool Kit (Reindeer Graphics, Inc.). 
 
 
2.2.4 Real-time PCR 
 
Genomic DNA was phenol/chloroform extracted from frozen sections and 
suspended in TE buffer. DNA concentration was determined from the A260 as measured 
using an Ultrospec 2000 UV/Visible Spectrophotometer (Pharmacia Biotech). Standard 
DNA was serially diluted at 1:5 from a starting concentration of 100#g/µL. Unknown 
samples were diluted to 100#g/µL, such that each reaction contained an equal amount of 
DNA. DNA was added to iQ™ SYBR® Green supermix (BioRad) containing forward 
and reverse primers for either the Lig4 coding region or $-actin. PCR reaction was 
carried out using the iQ™5 Multicolor Real-Time PCR Detection System (BioRad). 
Measurement numbers were automatically assigned based on SYBR green amounts fit to 
a standard curve. The amount of Lig4 product was normalized to that of $-actin for each 
sample.  
 
Lig4 forward primer: 5’ ACTATACCGACCAGTTTGGTGAATC  
Lig4 reverse primer: 5’ CCCGAACGCATTGTGAATAA 
!-actin forward primer: 5’ CAGCAAGCAGGAGTACGATGAG 
!-actin reverse primer: 5’ CAGTAACAGTCCGCCTAGAAGCA 
 
 
2.3  Results 
 
 
2.3.1 Kinetics of H2AX phosphorylation in Atm, Mre11, Nbs1, or 
Lig4-deficient astrocytes 
 
Histone H2A is conserved between eukaryotes and is classified into the 
subfamililies H2A1, H2A2, H2AZ, and H2AX. The NH2- and COOH- tails are targets for 
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post-translational modifications including phosphorylation, methylation, acetylation, and 
ubiquitination (Takahashi & Ohnishi, 2005). Phosphorylation of H2AX serine 129 at the 
–COOH terminus is one of the first responses to DNA DSBs, occurring within 3 minutes 
following irradiation. This phosphorylation event has been attributed to overlapping 
activity between ATM and DNA-PKcs in non-replicating cells (Kuhne et al., 2004; 
Rogakou et al., 1998; Stiff et al., 2004). The modified histone is termed "-H2AX, and can 
be visualized through immunoflourescence as punctate nuclear foci. Pulse-field gel 
electrophoresis (PFGE) is an established method of measuring DSBs that has been shown 
to correlate with the amount of "-H2AX foci observed in cells after irradiation, and is 
thus widely used as a quantitative measure of DSB repair. Both methods were employed 
to study repair defects in fibroblasts isolated from an A-T individual and a LIG4 
syndrome patient. The A-T cells showed no deficient repair based on PFGE and 
prolonged persistence of "-H2AX foci after IR. In contrast, the LIG4 syndrome cells 
showed proficient repair even several days after prolonged exposure to IR (Kuhne et al., 
2004).  
 
Astrocytes were isolated from Lig4
Nes-cre
, Atm
-/-
, Mre11
ATLD1/ATLD1
, and Nbs1
!B/!B
 
post-natal day 4 (P4) pups to compare the DNA damage response in murine neural cells. 
In contrast to the Kuhne et al. report of proficient resolution of DSBs in LIG4 syndrome 
fibroblasts, Lig4
Nes-cre 
astrocytes showed increased presence of "-H2AX foci in untreated 
cells and dramatic persistence of foci over a prolonged recovery time. This difference 
from the LIG4 syndrome fibroblasts reflects the diminished repair capacity associated 
with LIG4 hypomorphic mutations, in contrast to complete loss of Lig4. Thus, Lig4
Nes-cre 
astrocytes served as a positive control for DNA DSB repair deficiency. Concurrent with 
reported findings in A-T fibroblasts, Atm
-/-
 astrocytes showed abrogated H2AX 
phosphorylation at earlier times post-IR, but there was a statistically insignificant 
increase in residual foci 6 hours post-IR perhaps suggesting a minor DSB repair 
deficiency. Because ATM is reportedly the major kinase responsible for H2AX 
phosphorylation (ATR and DNA-PK share H2AX as a common substrate as well), we 
reasoned that the Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B 
mutations would mimic repair kinetics 
in Atm
-/-
 astrocytes if Atm activity was compromised (Burma and Chen, 2004; Stiff et al., 
2004; Wang et al., 2005b). Mre11
ATLD1/ATLD1
 astrocytes showed a pattern of H2AX 
phosphorylation that was largely indistinguishable from that seen in the Atm
-/-
 cells. 
Nbs1
!B/!B
 astrocytes showed a less pronounced abrogation of H2AX phosphorylation 10 
min post-IR than observed in either the WT or Mre11
ATLD1/ATLD1
 cells. However, 6 hours 
post-IR, the Nbs1
!B/!B
 astrocytes showed a statistically insignificant increase in the 
number of residual foci compared to the WT control (Figures 2.1 and 2.2). Variability 
and large standard deviations make this data difficult to interpret, thus firm conclusions 
cannot be drawn from it.  
 
 
2.3.2 IR-induced apoptosis is defective in the Mre11
ATLD1/ATLD1 
brain 
  
 To determine the basis for the differential neuropathology associated with ATLD 
and NBS we used mice harboring hypomorphic alleles (Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
) 
corresponding to the human diseases (Carney et al., 1998; Stewart et al., 1999; Varon et  
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Figure 2.1 Kinetics of H2AX phosphorylation in Lig4
Nes-cre
, Atm
-/-
, Mre11
ATLD1/ATLD1
, 
and Nbs1
!B/!B
 astrocytes.  
Astrocytes were generated from P4 mice of the indicated genotypes. Cells were seeded 
onto chambered slides and allowed to grow 48 hours prior to being either mock treated or 
irradiated at a dose of 3 grays (Gy). Cells were allowed to recover for the indicated times, 
then were stained via indirect immunofluorescence against "-H2AX (green). Nuclei were 
counterstained with DAPI (blue). Images were taken at 400x magnification. 
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Figure 2.2 DNA DSB repair kinetics in Lig4
Nes-cre
, Atm
-/-
, Mre11
ATLD1/ATLD1
, and 
Nbs1
!B/!B
 astrocytes. 
"-H2AX foci were quantified from the images represented in Figure 2.1 using the 
Adobe® Photoshop® plugin Image Processing Tool Kit (Reindeer Graphics, Inc.). Error 
bars represent standard deviation between the results of 2 independent experiments 
performed with cells isolated from different animals. For each experiment, foci were 
counted in no less than 20 cells per genotype. 
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al., 1998). The ATLD mutation (633R!STOP) results in a truncated Mre11 protein, 
while the NBS mouse has a truncating mutation of Nbs1 that produces an 80 kDa protein 
lacking the N-terminal FHA and BRCT domains (Theunissen et al., 2003; Williams et al., 
2002). These mice recapitulate many aspects of the respective human syndromes 
including radiosensitivity and cell cycle checkpoint defects, although they do not develop 
overt neuropathology (Theunissen et al., 2003; Williams et al., 2002). 
 
While many features of NBS and ATLD can be attributed to a defect in ATM 
activation (Carson et al., 2003; Difilippantonio et al., 2005; Uziel et al., 2003), the 
disparate neuropathology suggests differences in DNA damage signaling in the nervous 
system. To investigate DNA damage responses in the developing nervous system of 
ATLD and NBS mice, we used ionizing radiation (IR) to induce genotoxic stress. 
Because apoptosis is a primary readout of IR-induced DNA damage in the developing 
nervous system (Difilippantonio et al., 2007), we analyzed this in the postnatal retina and 
dentate gyrus using immunohistochemistry to assess caspase-3 activation. In the absence 
of radiation no caspase-3 positive cells were seen (Figure 2.3). However after radiation, 
wild type (WT) and Nbs1
!B/!B
 mice showed an equivalent susceptibility to IR-induced 
apoptosis (Figure 2.3A c-f). In contrast, there was a marked resistance to apoptosis in the 
Mre11
ATLD1/ATLD1
 mice (Figure 2.3A g,h). IR-induced cell death was substantially 
reduced throughout immature postmitotic regions of the Mre11
ATLD1/ATLD1 
developing 
nervous system, including the inner nuclear layer of the retina and the dentate gyrus of 
the hippocampus (Figure 2.3A g, h). The resistance of these particular cell populations is 
similar to that observed in the same regions in the Atm
-/-
 brain (Herzog et al., 1998; Lee et 
al., 2001). IR treatment of Mre11
ATLD1/ATLD1
 (and Atm
-/-
) embryos at E13.5 and E15.5 also 
showed resistance to apoptosis in immature, postmitotic neurons akin to the P5 tissues, 
while in Nbs1
!B/!B
 embryos IR-induced apoptosis was indistinguishable from WT 
embryos. Importantly, IR-induced apoptosis in the proliferating ventricular zone of the 
embryonic nervous system occurred normally in Mre11
ATLD1/ATLD1
 (and Nbs1
!B/!B
) as it 
does in Atm
-/-
 tissue (data not shown). Thus, ATLD but not NBS mutations measurably 
influence DNA damage-induced apoptosis in specific regions of the developing brain.  
 
Because the MRN complex can modulate ATM kinase activity, we determined if 
the resistance to IR-induced apoptosis in the Mre11
ATLD1/ATLD1 
tissue was related to 
defective Atm activity. Dr. Youngsoo Lee, in the McKinnon lab, assayed Atm ser1987 
phosphorylation (equivalent to ser1981 of human ATM) as a marker for DNA damage-
induced Atm activation in vivo in Mre11
ATLD1/ATLD1 
and Nbs1
!B/!B
 P5 cerebellum, a tissue 
significantly affected in both diseases. At doses of 1Gy or below, very little Atm ser1987 
phosphorylation was observed in either Mre11
ATLD1/ATLD1 
or Nbs1
!B/!B
 tissue compared to 
WT cerebellum (Figure 2.4A). However, at higher radiation levels (>4Gy) Atm 
phosphorylation was evident in Mre11
ATLD1/ATLD1 
and Nbs1
!B/!B
 tissue, albeit reduced 
compared to WT (Figure 2.4A). These data indicate that both Mre11 and Nbs1 mutations 
result in reduced Atm ser1987 phosphorylation, indicating MRN modulates Atm 
signaling in the developing brain. As Nbs1
!B/!B
 neural tissue underwent IR-induced 
apoptosis similar to WT (Figure 2.3), defective Atm phosphorylation was somewhat 
unexpected. Therefore, we confirmed disruption of the MRN complex in 
Mre11
ATLD1/ATLD1 
and Nbs1
!B/!B
 tissue. Jingfeng Zhao, in the McKinnon lab, showed that  
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Figure 2.3 Radiation-induced apoptosis in Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
 CNS.  
(A) WT, Mre11
ATLD1/ATLD1 
 and Nbs1
!B/!B
 mice were treated with 8Gy of "-irradiation and 
collected 6 hr post-IR. Immunostaining was performed against active-caspase 3. Images 
of the retina (a, c, e, g) are at 400x magnification. Images of the dentate gyrus (b, d, f, h) 
are at 200x magnification. Retinal photoreceptor layer (PR), inner nuclear layer (INL), 
plexiform layer (PL) are indicated. Arrows point to immunopositive cells. (B) 
Quantitation of the total number of active-caspase 3 positive cells in the retina. Error bars 
represent standard deviation. (C) Quantitation of the total number of active-caspase 3 
positive cells in the dentate gyrus. Error bars represent standard deviation. 
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Figure 2.4 DNA damage responses in the Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
 nervous 
systems. 
(A) WT, Mre11
ATLD1/ATLD1
, and Nbs1
!B/!B
 mice were treated with indicated doses of "-
irradiation and cerebella were harvested 30 min post-IR. Total Atm was 
immunoprecipitated from cerebellar lysates followed by immunoblotting against Atm 
pSer1987. Total Atm served as the loading control. Corrections were made for loading by 
normalization of Atm pSer1987 bands to total Atm. Quantitative analysis depicted under 
the Atm pSer1987 bands. (B) WT, Mre11
ATLD1/ATLD1
, and Nbs1
!B/!B
 mice were treated 
with indicated doses of "-irradiation and cerebella were harvested 3 hr post-IR. 
Cerebellar lysates were probed using antibodies recognizing Nbs1, Mre11 and Chk2. 
Phosphorylated Chk2 (pChk2) was detected as a mobility shift. $-actin was the loading 
control. (C) WT, Mre11
ATLD1/ATLD1
, and Nbs1
!B/!B
 mice were treated with 18 Gy of "-
irradiation and sacrificed 4 hr post-IR. Immunostaining was performed against p53-
phosphoserine 18 and active-caspase 3. Micrographs depict cerebellum and are at 200x 
magnification. (D) WT, Atm
-/-
 and Mre11
ATLD1/ATLD1
 were treated with 4Gy of IR to 
determine Chk2 and p53 phosphorylation in Atm
-/-
 cerebellum. (E) WT, Mre11
ATLD1/ATLD1
 
and Nbs1
!B/!B
 mice were treated with 18Gy of "-irradiation and collected 3 hr post-IR. 
Cerebellar lysates in D and E were probed for Chk2, p53 (pSer18) and Nbs1 or Mre11. 
Ponceau staining was used to determine equal loading. The p53(s18) levels were 
normalized to the upper band of the Ponceau stain, as indicated by numbers above the 
bands.  
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full length Nbs1 was not present in the Nbs1
!B/!B
 samples (Figure 2.4B), although he did 
detect the 80 kDa product translated from the Nbs1 mutant message (Maser et al., 2001).  
Similarly, the COOH-terminus of Mre11 was not detected in Mre11
ATLD1/ATLD1 
tissue and 
levels of Nbs1 were also substantially reduced (Figure 2.4B). Consequently, we 
determined other readouts of Atm signaling relevant to apoptosis. Chk2 is a key DNA 
damage signaling effector that is activated by Atm-dependent phosphorylation (Ahn et 
al., 2000; Hirao et al., 2000; Matsuoka et al., 2000), and is essential for radiation-induced 
apoptosis in the developing nervous system (Takai et al., 2002). In both Mre11
ATLD1/ATLD1
 
and Nbs1
!B/!B
 tissues, Mr. Zhao found that there was clearly less Chk2 modification 
compared with WT after irradiation. However, despite this, Chk2 activation was 
substantially greater in the Nbs1
!B/!B
 tissue compared to Mre11
ATLD1/ATLD1
 particularly 
after 8Gy (Figure 2.4B). We also evaluated ser-18 phosphorylation of p53 (equivalent to 
serine-15 of human p53) after radiation of P5 cerebellum using immunohistochemistry 
and western blot analysis. While both WT and Nbs1
!B/!B
 tissue had robust induction of 
p53 ser18 phosphorylation and caspase-3 activation, both were markedly reduced in 
Mre11
ATLD1/ATLD1
 tissue (Figure 2.4C). Furthermore, Mr. Zhao also determined the 
relative level of Chk2 activation in Atm
-/-
 P5 cerebellum, as a comparison to the MRN 
mutants, and found that no Chk2 activation or p53ser18 phosphorylation occurred after 
4Gy of IR, consistent with apoptosis being Atm-dependent in this tissue (Figure 2.4D). 
Additionally, he found that at higher radiation doses (18Gy) the difference between Chk2 
activation in Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
 is more apparent, as is, albeit to a lesser 
degree, phosphorylation of p53ser18 (Figure 2.4E). The abundant apoptosis and Chk2 
modification observed in the Nbs1
!B/!B
 mice indicate that the hypomorphic Nbs1 allele 
can activate Atm sufficiently to engage apoptosis in the CNS after DNA damage. We 
also observed defects in Atm signaling in the Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
 thymus, 
with reduced apoptosis in ATLD tissue (data not shown), consistent with recent data 
using Mre11
ATLD1/ATLD1
 thymocytes (Stracker et al., 2008). Thus, the MRN complex is 
required for ATM activation, and this is defective in both Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
 
tissue. However, the Mre11
ATLD1/ATLD1
 mutation results in a more substantial block in Atm 
activation that includes abrogation of apoptosis.  
 
 
2.3.3  Characterization of Lig4
Nes-cre
 mice 
 
The Lig4
Nes-cre
 animal model was generated to be used as a tool in which to study 
the chronic consequences of endogenously-occurring DNA damage in the nervous 
system. Dr. Helen Russell generated the mice through restriction enzyme-mediated 
cloning and performed southern and northern blots using DNA extracted from various 
tissues of embryonic to P5 aged mice to confirm efficiency and specificity of gene 
deletion in the Nestin-cre background. I used real-time PCR analysis to verify deletion of 
the Lig4 open reading frame in the E13.5 CNS (Figure 2.5). 
 
Lig4
Nes-cre
 mice were born at the expected frequency and were viable into 
adulthood. Initial histological analysis revealed pronounced microcephaly, but largely 
normal cellular and gross morphology (Figure 2.6). Though apparently healthy, it was  
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Figure 2.5 Real-time PCR demonstrating Lig4 gene excision in E13.5 Lig4
Nes-cre
 CNS. 
Embryonic brain and spinal was isolated from cryosections. DNA was phenol/chloroform 
extracted. Error bars represent standard deviation between duplicate results using DNA 
from the same sample. 
 
 
 
 
 
 
Figure 2.6 Diminished cerebellar size reflective of overall microcephaly in Lig4
Nes-cre
 
mice.  
Five month old Lig4
Ctrl
 and Lig4
Nes-cre
 mice were transcardially perfused and frozen 
sections (10 µm thick) were stained for hematoxylin and eosin (H&E). Photomicrographs 
were taken at 25x magnification. 
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noticed that Lig4
Nes-cre 
females tended to produce small litters often with less than 5 pups 
and ceased to efficiently reproduce around 4 months of age. In addition, two Lig4
Nes-cre
 
males that were placed with healthy Lig4
+/loxP
 females not expressing cre failed to mate. 
Notably, around 4 months of age these animals began to appear vaguely unhealthy (i.e., 
rough coat and lethargic). Between 4-6 months of age all Lig4
Nes-cre
 began to develop 
mild hindlimb ataxia most noticeable as loss of balance that progressed to an inability to 
move the hindlimbs forward such that dragging the legs was the only means of mobility. 
Full hindlimb paralysis was not observed either because the pathology had not progressed 
to its full extent at the time of euthanasia or the mechanism behind this phenomenon 
failed to cause paralysis. This phenotype was observed in all Lig4
Nes-cre
 animals aged to at 
least 1 year (at least 20 animals) and was not seen in an equal number of age-matched 
controls. Despite dramatic phenotypic penetrance, no neuropathology was found that 
would account for this presentation. No degeneration was observed in adult Lig4
Nes-cre
 
brain or spinal cord based on TUNEL and FluoroJade C staining (data not shown). 
Presentation appeared consistent with spinal cord damage, thus analysis of the vertebrae 
and spinal cord was performed. In conjunction with the St. Jude Children’s Research 
Hospital Animal Imaging Center, CT scans were taken of the entire vertebral column of 
Lig4
Nes-cre
 mice that exhibited severe hindlimb impairment and age-matched controls to 
determine if bone malformations might have caused compression of the spinal cord 
(Figure 2.7). No evidence of such occurrence was observed (Personal communication 
with Dr. Chris Calabrese, April 18, 2007).  
 
Histology of the lumbar spinal cord was performed. Toluidine blue staining was 
used to assess white matter tracts and Nissl stain was used to look at neuronal soma. 
Neither stain revealed evidence of pathology (data not shown). Similarly, H&E staining 
failed to detect degenerative changes in the Lig
Nes-cre
 spinal cord and immunostaining 
against myelin basic protein showed normal patterns of myelination compared to age-
matched and sex-matched Lig4
Ctrl
 samples (Figure 2.8). Cellularity did appear to be 
decreased in the spinal cord, based upon H&E staining. This was not confirmed through 
quantitation and likely reflects cell loss during development. All panels were taken at the 
same magnification. H&E panels taken at low magnification demonstrate that similar to 
microcephaly observed in the Lig
Nes-cre
 mice, the spinal cord is much smaller compared to 
controls. 
 
Though Lig4
-/-
 embryos exhibited extensive Atm/p53-dependant apoptosis in the 
nervous system prior to death, it has not been formally shown (though assumed) that the 
accumulation of unrepaired DSBs were the reason for cellular demise. The Lig4
Nes-cre
 
mice were valuable as a tool with which the inherent occurrence and consequences of 
DNA damage could be observed in the mammalian nervous system from embryonic life 
through adulthood. Similar to the DNA damage response described in astrocytes, 
immunostaining against "-H2AX and 53BP1 was used to track the appearance and 
resolution of DNA damage. Failed attempts were made at performing pulsed-field gel 
electrophoresis directly upon tissue samples to corroborate immunostaining (data not 
shown). Foci were rarely observed in Lig4
Ctrl
 animals and typically appeared only in a 
few cells throughout the entire brain (Figures 2.9-2.11). In those few cells, less than five 
foci were typically observed. Spatiotemporal mapping of foci in Lig4
Nes-cre
 mice revealed  
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Figure 2.7 CT scan of spinal column collected from Lig4
Nes-cre
 mouse with end-stage 
hindlimb ataxia and age-matched Lig4
Ctrl
.  
Personal communication with Dr. Chris Calabrese, April 18, 2007. 
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Figure 2.8 Histology observed in Lig4
Nes-cre
 spinal cord. 
Upper panels show H&E stained paraffin sections of 12 month old Lig4
Ctrl
 and Lig4
Nes-cre
 
spinal cord (25x magnification). Insets of the dorsal horn are shown in the lower left 
corner of each panel (200x magnification). Lower panels show dorsal horn of 12 month 
old Lig4
Ctrl
 and Lig4
Nes-cre
 spinal cord immunostained against myelin basic protein (400x 
magnification). 
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Figure 2.9 Pattern of 53BP1 foci in E15.5 Lig4
Nes-cre
 brain. 
53BP1 were observed in the indicated areas of the Lig4
Nes-cre 
embryonic brain. Age-
matched Lig4
Ctrl
 samples showed diffuse nuclear staining of 53BP1 (A, C, E insets) 
rather than punctuate foci (B, D, F insets). Photomicrographs were captured at 200x 
magnification. 
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Figure 2.10 Comparison of 53BP1 foci in caudate putamen of P5, 4 month old, and 
12 month old Lig4
Nes-cre
 mice. 
Photomicrographs were captured at 200x magnification. Arrows indicate distinct foci. 
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Figure 2.11 Comparison of "-H2AX expression in cerebella of P4, 4 month old, and 
12 month old Lig4
Nes-cre
 mice. 
Photomicrographs were captured at 200x magnification.  
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that DNA DSBs arise during embryogenesis and continue to accumulate during 
adulthood (up to 1 year of age) in the brain (Figures 2.9-2.12). Semi-quantitative  
mapping throughout major regions of the postnatal and adult Lig4
Nes-cre 
brains revealed 
that there is no striking regional or cell-type specificity in which damage occurs. 
 
While endogenous DNA repair foci allowed us to see where damage occurs 
naturally in the brain, it provided only a snapshot in time of existing damage without 
indication of whether DSBs were being left unrepaired and accumulating, or if 
endogenous damage was occurring with a higher frequency in older animals. Given the 
role of Lig4 in NHEJ, 53BP1 and "-H2AX foci observed endogenously in the Lig4
Nes-cre
 
mice most likely represent the former. To ascertain the likelihood of this, repair capacity 
was measured in vivo through irradiation and prolonged recovery of age-matched Lig4
Nes-
cre
 and Lig4
Ctrl 
mice followed by immunostaining against 53BP1 (data not shown) and "-
H2AX (Figure 2.13). The results of this experiment indicated that little or no repair 
occurred in the Lig
Nes-cre
 brain up to 7 days post-IR, further suggesting that no significant 
back-up method of NHEJ exists in the nervous system. 
 
In summary, the Lig4
Nes-cre 
mutant is a viable mouse model of DNA ligase IV 
deficiency in the nervous system. Though microcephalic, these mice do not exhibit any 
other notable neuropathology. Microcephaly is likely attributable to increased apoptosis 
during neurogenesis, due to an overload of DNA DSBs in nascent post-mitotic cells. 
Despite the overwhelming presence of DNA damage in the adult Lig4
Nes-cre
 brain, 
apoptosis is not induced (data not shown). Thus, the unexplained hindlimb ataxia is 
difficult to directly relate to DNA damage, though how the accumulation of DNA DSBs 
affects function of viable neurons is unknown. 
 
 
2.3.4 Microcephaly after Lig4 loss requires Atm signaling 
 
 In comparison to age-matched and sex-matched littermates Lig4
Ctrl
 (Lig4
+/loxP
; 
Nestin-cre or Lig4
loxP/loxP
), Lig4
Nes-Cre
 animals exhibit pronounced microcephaly as 
evident by an approximately 40% reduction in brain size (Figure 2.14). Notably, 
microcephaly is a characteristic of LIG4 syndrome patients with hypomorphic mutations 
in LIG4 (O'Driscoll et al., 2004). To determine the cause of the microcephaly in the 
Lig4
Nes-Cre
 mice we assessed apoptosis at various developmental stages, and found that 
from E13.5 onwards there was markedly increased apoptosis in Lig4
Nes-Cre
 neural tissue 
as judged by TUNEL and caspase 3 staining (Figure 2.15), with a peak around E15.5 
somewhat similar to germline disruption of Lig4. Thus, microcephaly in Lig4
Nes-Cre
 mice 
likely results from apoptotic cell loss during development. Therefore we generated 
Lig4
Nes-Cre
;Atm
-/-
, Lig4
Nes-Cre
;Mre11
ATLD1/ATLD1
 or Lig4
Nes-Cre
;Nbs1
!B/!B
 mice to produce 
viable mice with which to monitor longer term consequences of MRN mutations. 
Initially, we confirmed that both MRN mutations produced effects in the Lig4
Nes-cre
 mice 
similar to those we observed after germ line disruption of Lig4. Apoptosis was abrogated 
in Lig4
Nes-Cre
;Mre11
ATLD1/ATLD1
 and Lig4
Nes-Cre
;Atm
-/-
 but occurred to the same level as 
Lig4
Nes-Cre
 in Lig4
Nes-Cre
;Nbs1
!B/!B
 mice (Figure 2.15). To assess the long-term  
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Figure 2.12 Spatiotemporal mapping of 53BP1 and H2AX foci in Lig4
Nes-cre
 brains. 
Foci were semi-quantitated manually at 400x magnification in the indicated regions of 
the brain at the indicated ages in Lig4
Ctrl
 and Lig4
Nes-cre
 samples. Data is shown for the 
Lig4
Nes-cre
 samples. As pictured in Figures 2.9 and 2.10, almost no cells contained DNA 
either 53BP1 or "-H2AX foci. Because the adult cerebellum contains only the granule 
cell layer, as the EGL no longer exists and the IGL is mature, these structures are 
designated as non-applicable in the 4mo and 12mo samples. That is indicated under the 
cerebellar granule cell layer in adult samples. Data is representative of 2 animals for each 
age analyzed. 
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Figure 2.13 "-H2AX foci persist in irradiated Lig4
Nes-cre
 brain.  
Littermate Lig4
Ctrl
 and Lig4
Nes-cre 
mice were either untreated or irradiated with 8 Gy IR at 
age P21. Irradiated animals were allowed to recover for either 1 or 7 days prior to 
collection of brains. Immunostaining was performed against "-H2AX (red) and nuclei 
were stained with DAPI (blue). Two animals were assessed for each recovery time. 
Photomicrographs were captured at 200x magnification.
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Figure 2.14 Mre11 hypomorphism and Atm loss partially rescue microcephaly in 
Lig4
Nes-cre
 mice.  
Measurement of A-T, A-TLD, and NBS mutations towards Lig4
Nes-Cre
 brain size. Brain 
weights were collected from sex-matched cohorts at 4 months of age. Error bars represent 
standard deviation, and “n” is the total number of animals. 
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Figure 2.15 Apoptosis in E15.5 Lig4
Nes-cre
 brain in Atm
-/-
, Mre11
ATLD1/ATLD1
, and 
Nbs1
!B/!B
 genetic backgrounds. 
TUNEL analysis and immunostaining for active caspase 3 were performed on E15.5 
embryos from indicated genotypes. The total number of positive cells per 400µm
2
 was 
quantified. Error bars represent standard deviation. Micrographs show ganglionic 
eminence and neopallial cortex at 200x magnification.  
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consequences of MRN dysfunction and chronic DNA damage in the CNS, we monitored 
adult Lig4
Nes-Cre
;Atm
-/-
, Lig4
Nes-Cre
;Mre11
ATLD1/ATLD1
 or Lig4
Nes-Cre
;Nbs1
!B/!B
 mice. 
Inactivation of either Atm or Mre11 significantly rescued microcephaly, whereas the 
Nbs1
!B/!B
 mutation had no obvious affect towards microcephaly in Lig4
Nes-Cre
 mice 
(Figure 2.14). Excluding microcephaly, no other significant morphologic aberrations 
were found in the Lig4
Nes-Cre
 brain. However, with age, adult Lig4
Nes-Cre
 animals 
developed a severe hindlimb ataxia of unknown etiology from 7-9 months onwards. 
Neither the Atm
-/-
, Mre11
ATLD1/ATLD1
, nor Nbs1
!B/!B
 background affected latency or 
severity of this phenotype, suggesting this later pathway is independent of MRN/ATM. 
Thus, the microcephalic phenotype in Lig4
Nes-Cre
 mice is attributable to increased 
apoptosis via ATM dependent DNA damage signaling. 
 
 
2.4  Discussion 
 
 Defective responses to DNA damage resulting from dysfunction of ATM or the 
MRN complex can cause the human syndromes A-T, ATLD, and NBS. Although these 
diseases share similar phenotypes including radiosensitivity and chromosomal instability, 
A-T and ATLD exhibit neurodegeneration while NBS is characterized by microcephaly. 
This suggests that the respective disease-causing mutations impact DNA damage 
signaling differently within the brain. To test this, we analyzed the DNA damage 
response in the nervous systems of ATLD (Mre11
ATLD1/ATLD1
) and NBS (Nbs1
!B/!B
) mice 
and found that different effects upon ATM activation and downstream apoptotic 
signaling distinguish these MRN mutations. Therefore, we hypothesize that the different 
neuropathology in ATLD and NBS is a result of the relative levels of ATM activation by 
MRN after DNA damage, most probably in response to DNA DSBs. 
 
While both Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
 are defective in Atm phosphorylation 
after DNA damage, only Mre11
ATLD1/ATLD1
 mutations block the subsequent activation of 
apoptosis by Atm. In this manner, the Mre11
ATLD1/ATLD1
 mutation creates a scenario 
similar to the Atm
-/-
 nervous system whereby defective ATM signaling inhibits apoptosis 
of DNA-damaged neural cells (Lee et al., 2001). Therefore our data provide a 
mechanistic explanation for the similar neuropathology between A-T and ATLD. We 
have previously suggested that the loss of ATM prevents apoptosis, leading to 
incorporation of cells harboring genomic damage into the mature nervous system, and 
over time these cells presumably succumb to this damage and die (Herzog et al., 1998; 
Lee et al., 2001). Thus, attenuation of DNA damage-dependent apoptosis in ATLD would 
mimic A-T, resulting in neurodegeneration characteristic of each disease. 
 
Conversely, in NBS, DNA damage accumulates due to dysfunctional MRN, but 
Nbs1 mutations do not block Atm-dependent apoptosis and therefore we predict that 
increased apoptosis occurs during development contributing to microcephaly. This is 
consistent with defective NBS1 leading to increased genotoxic stress, cancer and 
radiosensitivity (Kobayashi et al., 2004). As opposed to the Nbs1
!B/!B
 mice, complete 
disruption of Nbs1 in the murine nervous system leads to microcephaly from DNA 
damage-induced apoptosis and decreased proliferation (Frappart et al., 2005). In contrast 
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to the microcephaly observed in LIG4 syndrome and modeled in the Lig4
Nes-cre
 mice, 
neuropathology associated with NBS could be due to damage accumulation in either 
post-mitotic or proliferating cells as NBS1 is also important during HR (Limbo et al., 
2007; Sartori et al., 2007; Tauchi et al., 2002). The Nbs1
!B
 allele results from deletion of 
exons 4 and 5, producing a protein that lacks the N-terminal FHA and BRCT domains 
encoded within exons 1 through 5. In contrast to the Nbs1
!B/!B
 mouse, other models that 
lack a C-terminus (Nbs1
!C/!C
 and Nbs1
tr735
), showed reduced apoptosis in some tissues 
consistent with a defect in ATM activation (Difilippantonio et al., 2007; Stracker et al., 
2007). Additionally, deletion of the Nbs1 C-terminus in the context of the Nbs1
%B
 protein 
(the Nbs1
!BC
 allele) results in apoptotic defects in thymocytes but does not rescue 
gestational lethality associated with Lig4 loss (data not shown) which is linked to 
neuraxis-wide apoptosis, suggesting that modulation of apoptosis by Nbs1 is tissue-
specific. 
 
As NBS individuals harbor mutations in the FHA and BRCT domains, not the C-
terminus, the pathology associated with NBS involves an intact C-terminus. Preservation 
of the C-terminus presumably allows interaction of the resulting NBS1 protein with ATM 
and Mre11, and the activation of apoptosis. Although the level of Nbs1 is reduced in 
Mre11
ATLD1/ATLD1
 cells, there is still a relatively higher level than that of the NBS1 p80 
protein found in Nbs1
!B/!B
 tissue. This suggests that the apoptotic defect we observe in 
the Mre11
ATLD1/ATLD1
 nervous system directly involves the Mre11 mutant protein rather 
than an indirect effect upon Nbs1. Given the multiple contacts ATM makes with the 
MRN complex, it is likely that ATLD mutations directly and selectively impact ATM-
MRN interactions to preclude effective ATM activation (Lee & Paull, 2004). 
 
Why then do A-T and NBS have many phenotypic similarities outside of the 
nervous system? These similarities encompass immunodeficiency, cancer and 
radiosensitivity, and reflect the interrelated roles of MRN and ATM during DNA 
rearrangements in the immune system and maintenance of genomic integrity in 
proliferating cells. For example, ATM and NBS1 are required to ensure the fidelity of 
programmed rearrangements and elimination of cells with inappropriate genomic 
rearrangements in the immune system (Bredemeyer et al., 2006; Callen et al., 2007; 
Jankovic et al., 2007; Kracker et al., 2005; Reina-San-Martin et al., 2005). Additionally, 
both ATM and NBS1 can function in stem and progenitor populations in the 
hematopoietic and germ cell compartments (Ito et al., 2004; Kang et al., 2002; Takubo et 
al., 2008). These requirements for ATM and NBS1 contrast the situation in the nervous 
system where ATM fulfills an indispensable role in DNA damage-induced apoptosis in 
postmitotic neurons, but not in proliferating neural progenitors where ATR or DNA-PK 
may be the more important kinases (Lee et al., 2001; Orii et al., 2006). 
 
In summary, our data demonstrate that the respective MRN mutations that lead to 
NBS and ATLD impact differently upon ATM signaling. These data illuminate the 
mechanistic underpinnings of the different neuropathology present in ATLD and NBS, 
suggesting they result from alterations in the modulation of ATM-dependent apoptosis 
after DNA damage (Shull et al., 2009). 
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CHAPTER 3  ATR IS REQUIRED FOR GENOMIC 
INTEGRITY AND PROLIFERATION OF NEURAL 
PROGENITORS 
 
 
3.1  Introduction 
 
 The three major phosphoinositol 3-kinase (PI3K)-related protein kinases (PIKKs) 
involved in signal transduction of the DNA damage response are ataxia-telangiectasia 
mutated (ATM), ATM and RAD3-related (ATR), and DNA-Protein Kinase catalytic 
subunit (DNA-PKcs). ATM and ATR are highly similar in structure and share many 
overlapping substrates. Both kinases have a preference for phosphorylating serine or 
threonine residues that are followed by a glycine (Cimprich & Cortez, 2008). Recent 
proteomic analysis identified about 700 substrates phosphorylated on ser-gln and thr-gln 
sites recognized by ATM and ATR, in response to DNA damage. A few examples of 
such substrates include FANCD2, MDC1, 53BP1, and Orc3 (Matsuoka et al., 2007). 
ATR has also been reported to phosphorylate both Chk1 and Chk2 (a major ATM 
substrate) in response to cisplatin (Pabla et al., 2008). Additionally, both ATR and ATM 
reportedly phosphorylate p53 as well (Banin et al., 1998; Khanna et al., 1998; Tibbetts et 
al., 1999). Despite these similarities, ATM and ATR are functionally distinct, as evident 
by early embryonic lethality of Atr
-/-
 mice versus the viability of Atm
-/-
 mice (Barlow et 
al., 1996a; Brown and Baltimore, 2000; Brown et al., 1997; Elson et al., 1996b). 
Inactivating ATM mutations cause the syndrome ataxia-telangiectasia, which is 
characterized by neurodegeneration, cancer predisposition, immunodeficiency, 
radiosensitivity, and ocular telangiectasia (Gilad et al., 1996; Savitsky et al., 1995). 
Hypomorphic mutations in ATR have been identified in a few individuals with Seckel 
syndrome, which is an autosomal recessive condition characterized by low birth weight, 
micrognathia, beak-like protrusion of nose, and microcephaly. Mental retardation has 
been reported in some cases of Seckel syndrome (O'Driscoll et al., 2003). The 
distinctions between the physiologic requirements of ATM and ATR suggest that though 
these genes may serve some overlapping roles in DNA damage signaling, each likely 
fulfills an individual obligation largely dictated by cell type, proliferation status, and the 
form of damage incurred.  
 
 It has been shown in Atm
-/-
 mice that newly post-mitotic cells of the developing 
brain require Atm for apoptotic induction following IR-induced damage. Lig4-deficiency 
results in Atm-dependant apoptosis of post-mitotic neuron populations during 
embryogenesis, whereas Xrcc2
-/-
 embryos exhibit Atm-independent apoptosis localized to 
proliferating cells in the developing brain (Orii et al., 2006). This difference in Atm 
requirement during NHEJ versus during homologous recombination and its non-essential 
status during embryogenesis suggest that Atm is not the primary signaling molecule 
adapted to the DDR in proliferating neural precursors. Atr is required for embryonic 
gastrulation and is involved in maintaining integrity of proliferating tissues in adult mice, 
with little or no obvious requirement in largely post-mitotic organs such as the mature 
brain (Brown & Baltimore, 2000; Ruzankina et al., 2007). While ATM is typically 
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described as responding to double strand breaks, ATR activity is associated with multiple 
forms of damage including replication stress-induced DNA damage, UV-induced 
pyrimidine dimmers, and base adducts (Cimprich & Cortez, 2008; Mordes et al., 2008). 
However, phosphorylation of H2AX on ser 139 is a key characteristic of the DSB 
response, which can occur as a result of DNA damage from replication fork collapse. 
Recent in vitro studies have shown that replication fork collapse in the absence of ATR 
results in H2AX phosphorylation by ATM and DNA-PKcs, and that the accumulation of 
Rad51 foci (evidence of homologous recombination) is largely dependant upon H2AX 
(Chanoux et al., 2008). These results indicate that ATR-dependent replication fork 
stabilization and ATM/DNA-PKcs-mediated H2AX phosphorylation cooperatively 
function in response to DSBs generated by replication fork collapse. Thus, despite 
distinct physiologic requirements and separate modes of activation, ATM and ATR likely 
act synergistically to ensure genomic integrity during all stages of life. 
 
 Replication protein A (RPA)-coated stretches of ssDNA are formed during 
replication, and are important for localizing ATR to damage sites (Costanzo et al., 2003; 
Zou & Elledge, 2003). ATR-interacting protein (ATRIP) is an essential co-factor for 
ATR and is required for targeting ATR to RPA-coated ssDNA, to which it directly binds 
(Ball et al., 2007; Cortez et al., 2001). Additionally, topoisomerase (DNA) II binding 
protein 1 (TopBP1), is involved in activation of the ATR-ATRIP complex through 
interactions with both ATRIP and ATR (Kumagai et al., 2006; Mordes et al., 2008). ATR 
signaling further depends on the RAD9-RAD1-HUS1 (911) complex that recognizes a 
DNA end adjacent to RPA bound ssDNA (Bermudez et al., 2003; Ellison & Stillman, 
2003; Zou et al., 2003). ATM activation occurs through a different series of signaling 
events involving autophosphorylation and dependence upon the MRN complex 
(Bakkenist & Kastan, 2003; Cerosaletti & Concannon, 2004; Cerosaletti et al., 2006; 
Kozlov et al., 2006; Lee & Paull, 2004; Lee & Paull, 2005). Figure 3.1 depicts simple 
models for the separate activation mechanisms and consequent signaling pathways of 
ATM and ATR (Cimprich & Cortez, 2008) In vitro studies using Xenopus egg extracts 
and various mammalian cell lines have implicated MRN-dependent ATM activity as an 
ATR activator through phosphorylation of TopBP1 in a cell cycle specific manner 
(Adams et al., 2006; Cuadrado et al., 2006; Jazayeri et al., 2006; Myers & Cortez, 2006; 
Yoo et al., 2007). Alternatively, it has been reported that ATR phosphorylates and 
activates ATM in response to UV and replication fork stalling in ATR-Seckel fibroblasts 
(Stiff et al., 2006). Thus, while ATR and ATM are thought to have predominantly distinct 
signaling mechanisms, there is also evidence of interacting mechanisms in addition to 
overlapping substrates between the two kinases. Nonetheless, the interrelationship 
between ATR and ATM is complex, and many aspects remain to be elucidated. 
Deciphering the relevance of in vitro data to in vivo tissue-specificity of ATR function 
remains a challenge as well. 
 
 To determine what relationship exists between ATR and ATM signaling in the 
nervous system, we used a conditional knock-out strain to inactivate Atr in the nervous 
system by breeding it onto a Nestin-cre transgenic line (Brown & Baltimore, 2000). 
Atr
loxP/loxP
; Nestin-cre animals were born at a Mendelian frequency, but showed post-natal  
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Figure 3.1 Activation and signaling pathways of ATR and ATM. 
(a) The ATR-ATRIP and the 911 complexes are recruited to RPA-coated ssDNA. ATRIP 
binds RPA and the 911 clamp is loaded onto the 5’ primer junction with the aid of the 
RAD17-RFC2-5 complex. TopBP1 binds and activates ATR in an ATRIP-dependent 
manner. ATR is then able to phosphorylate Chk1 and other substrates to mediate origin 
firing, cell-cycle arrest, and replication fork stability. (b) DSB formation leads to H2AX 
phosphorylation and recruitment of the MRN complex and ATM to the break site. MRN 
activity promotes dissociation of the inactive ATM multimer into its monomeric form 
through autophosphorylation events. ATM binds to the MRN complex the Nbs1 C-
terminus. Binding of MDC1 to "-H2AX results in recruitment of additional ATM-MRN 
complexes to the damage site. ATM activity mediates the DSB response through 
phosphorylation of substrates such as Chk2. This figure was reprinted by permission 
from Macmillan Publisher Ltd: Nature Reviews Molecular Cell Biology Volume 9 No. 8 
(Cimprich & Cortez, 2008), copyright 2008, page 617.  
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lethality and neurogenesis defects associated with increased apoptosis and reduced 
proliferation of neural progenitor cells. Because the cerebellum was most dramatically 
affected and is of particular interest in comparing the requirement of ATM with that of 
ATR in the nervous system, most emphasis in this study was placed on that region. The 
cerebellum arises from the isthmus, which forms the metencephalic-mesencephalic 
junction of the neural tube (Hallonet & Le Douarin, 1993; Martinez et al., 1991). Lineage 
analysis using chick-quail chimeras revealed contribution of both the mesencephalic and 
metencephalic plates to formation of the cerebellar anlage (Hallonet & Le Douarin, 
1993). Cerebellar cells originate in the ventricular zone (VZ) and the rhombic lip. The 
ventricular zone lining the dorsal region of the fourth ventricle (V4) produces Purkinje 
cells (PCs) and interneurons. The rhombic lip arises between the neural tube and the roof 
plate of V4; it gives rise to granule cell precursors that migrate over the cerebellar surface 
to form the EGL. Cerebellar development is not complete until months after birth in 
humans or about P21 in mice (Carletti & Rossi, 2008; Goldowitz & Hamre, 1998; Sillitoe 
& Joyner, 2007; Wang & Zoghbi, 2001; Wingate, 2001). PCs exit the cell cycle and 
migrate into the cerebellar anlage between E11 and E13 in mice (Edwards et al., 1990; 
Miale & Sidman, 1961; Morales & Hatten, 2006). Purkinje cells mediate replication of 
the granule cell progenitors in the EGL, as transgenic mice in which Purkinje cells are 
ablated at specific developmental times showed reduced mitotic activation of EGL cells 
in regions corresponding to PC loss (Smeyne et al., 1995). PCs produce Sonic hedgehog, 
which regulates granule cell expansion through its receptor Patched (Goodrich et al., 
1997; Traiffort et al., 1998). Organization of the PCs into the mature monolayer depends 
upon proper formation and function of granule cells. This is apparent in Math1-null mice, 
in which improper granule cell generation leads to abnormal development of the PC layer 
(Ben-Arie et al., 1997). Rhombic lip cells are committed to becoming proliferative EGL 
neurons, and undergo final maturation and migration to form the inner granule layer 
(IGL) between birth and about P21, by which time proliferation is complete and the EGL 
has disappeared (Sillitoe & Joyner, 2007; Wang & Zoghbi, 2001). Figure 3.2 
demonstrates gross development of the murine cerebellum from E11 to adulthood 
(Goldowitz & Hamre, 1998). Figure 3.3 depicts post-natal development of the 
cerebellum, during which granule cells migrate through the Purkinje cell layer (PCL) to 
form the mature internal granule cell layer, and the dendritic arborizations fully maturate 
and extend their branches to the climbing fibers of the molecular layer (Goldowitz & 
Hamre, 1998). 
 
Despite numerous in vitro studies implicating a direct relationship between ATM 
and ATR signaling, our genetic analysis of Atm and Atr requirements indicate that these 
genes appear to function independently of each other in the CNS. We found that Atr is 
required in proliferating cells while as previously reported Atm is critical in post-mitotic 
neurons (Herzog et al., 1998; Lee et al., 2001; Ruzankina et al., 2007). Furthermore, we 
show that Atr loss induces p53-dependant apoptosis in proliferating neuroprogenitors and 
p53-independent cell cycle arrest that results in severe cerebellar dysgenesis, olfactory 
bulb malformation, and microcephaly, as well as growth delay and post-natal lethality. 
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Figure 3.2 Dramatic changes in cerebellar morphology that occur between 
embryogenesis and adulthood. 
Sagittal sections of the mouse cerebellum at E11, E13, E15, P0, P7, and adulthood show 
the dramatic increase in area and volume (bottom left graph) that occurs between early 
specification of the cerebellar anlage and maturation. Filled arrowheads indicate the 
neuroepithelium lining the dorsal wall of the fourth ventricle. Open arrowheads indicate 
the rhombic lip. Asterisks indicate the primary fissure. The timeline in the upper right 
corner illustrates some of the genes that are required for normal cerebellar development 
and the ages at which mutations in these genes manifest pathologically. Genes that are 
critical to early stages of development are in green. Genes specific to granule cells are 
denoted in blue, those specific to Purkinje cells are in red, and those associated with 
radial glia are in black. Abbreviations: external granular layer (EGL), Purkinje cell layer 
(P), internal granule cell layer (IGL). Reprinted from Trends in Neuroscience, Vol. 21, 
No. 9, Dan Goldowitz and Kristin Hamre, The cells and molecules that make a 
cerebellum, 375-382, 1998, with permission from Elsevier.  
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Figure 3.3 Depiction of post-natal cerebellar development. 
At birth, the external granule cell layer is comprised of an outer layer of proliferating 
granule cell precursors (blue) and inner layer of newly post-mitotic, differentiating 
granule cells (green). Upon exiting the cell cycle, differentiating granule cells migrate 
along radial glia fibers (black), through the Purkinje cell layer (red) and into the internal 
granule cell layer, where they fully differentiate into mature granule cells (dark green). 
Between P7 and P21, the EGL has disappeared and the dendritic arborizations of the 
Purkinje cells (PC) have matured into elaborate projections that connect with the 
climbing fibers of the molecular layer (ML). Expansion of the granule cells during post-
natal development results in an approximately 1000 fold increase in total cerebellar size 
between birth and P21 (Goldowitz & Hamre, 1998). Figure is courtesy of Dr. Peter 
McKinnon, February 10, 2009. 
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3.2  Experimental Procedures 
 
 
3.2.1  Animals 
 
Atr
loxP/loxP 
were obtained from Dr. Eric J. Brown and crossed onto a Nestin-cre 
transgenic line to achieve deletion throughout the nervous system.  
 
To generate a conditional Atm allele, Dr. Peter McKinnon obtained a murine 
BAC genomic clone (strain, 129Ola) containing the Atm genomic locus, into which he 
inserted a LoxP sequence into a unique BamHI site upstream of the targeted exon and a 
floxed NeoTK construct cloned into a XbaI site directly downstream of exon 58 to 
generate pAtm
loxP
. ES cells (W9.5; 129S1/SvImJ) were electroporated with linearized 
pAtm
LoxP
 and selected with G418 antibiotic. Correctly targeted cells were identified by  
southern blot analysis (Dr. Helen Russell). Targeted ES clones were then electroporated 
with pMC-cre, followed by selection in FIAU (5-iodo-2'-fluoro-2'deoxy-1- 
arabinofuranosyluracil) to kill cells containing TK. ES cells were then injected into 
blastocysts and the resultant chimeric mice assessed for germline transmission of the 
floxed Atm allele (St. Jude Children’s Research Hospital Transgenic Core). Nestin-cre 
mice (B6.Cg-Tg(Nes-cre)1Kln/J; JAX #003771) were used to delete Atm throughout the 
nervous system. 
 
Animals were housed in an Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC)-accredited facility and were maintained in 
accordance with the NIH Guide for the Care and Use of Laboratory Animals. The St. 
Jude Children’s Research Hospital IACUC approved all procedures for animal use. 
 
 
3.2.2  Real-time PCR 
 
Genomic DNA was phenol/chloroform extracted from frozen sections and 
suspended in TE buffer. DNA concentration was determined from the A260 as measured 
using an Ultrospec 2000 UV/Visible Spectrophotometer (Pharmacia Biotech). Standard 
DNA was serially diluted at 1:5 from a starting concentration of 100#g/µL. Unknown 
samples were diluted to 100#g/µL, such that each reaction contained an equal amount of 
DNA. $ DNA was added to iQ™ SYBR® Green supermix (BioRad) containing forward 
and reverse primers for either the targeted exon 44 of Atr/58 of Atm or the control exon 
29 of Atr/52 of Atm. PCR reaction was carried out using the iQ™5 Multicolor Real-Time 
PCR Detection System (BioRad). Measurement numbers were automatically assigned 
based on SYBR green amounts fit to a standard curve. The amount of the targeted exon 
product was normalized to that of the control exon for each sample.  
 
Atr exon 29 forward primer: 5’ ACTCTGGCTGTAGCGTCCTTTC 
Atr exon 29 reverse primer: 5’ TGCTTCTTTTCTGTAATAAATGACTCAAA 
Atr exon 44 forward primer: 5’ GAAAGGAGCTTCGCCAGTGT 
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Atr exon 44 reverse primer: 5’ GGGCAGGAGTAATTCTTGGAATAC 
Atm exon 52 forward primer: 5’ ATGGAATGAAGATTTCATCCTATAAGTTT 
Atm exon 52 reverse primer: 5’ ATCCTAGGCCTCCCGTCATTT 
Atm exon 58 forward primer: 5’ TCAGCGAAGCGGTGTTCTC 
Atm exon 58 reverse primer: 5’ TCATTTGGCCTGTATCTTCTATGTG 
 
 
3.2.3  Histology and immunohistochemistry 
 
Pregnant female mice were euthanized through cervical dislocation and embryos 
were drop-fixed in 4% PFA either overnight or 2-3 days depending upon age. Post-natal 
day 5 mice were sacrificed via transcardial perfusion using 4% PFA. Tissues were further 
fixed in 4% PFA overnight, and either cryoprotected in 25% PBS-buffered sucrose 
solution and embedded in O.C.T. (Tissue-Tek). Frozen tissue was sectioned at 10 µm 
thickness using a Microm HM500 M cryostat.  
 
Antigen retrieval was used for all immunohistochemistry using the anti-phospho-
"H2AX (1:50; Cell Signaling), anti-53BP1 polyclonal (1:500; Bethyl laboratories), anti-
p53 (CM5; 1:500; Vector Laboratories), anti-p53 phospho-Ser-15 (1:500; Cell 
Signaling), anti-active caspase 3 (1:500; BD Biosciences), anti-PCNA (1:500; Santa 
Cruz) and anti-Ki67 (1:1000; Vector Laboratories) antibodies. Antigen retrieval was not 
necessary for labeling with anti-Sox2 (1:1000; Chemicon) or anti-ssDNA (1:300; 
Chemicon). Immunostaining against anti-$ tubulin III TUJ1 (1:500; Babco) was equally 
efficient with or without antigen retrieval. For immunofluorescent staining, sections were 
subsequently immunolabelled with Cy3-conjugated goat anti-mouse (1:400; Jackson 
Immunoresearch) or FITC-conjugated goat anti-rabbit secondary antibodies (1:500; 
Jackson Immunoresearch) and mounted with Vectashield anti-fade reagent containing 
DAPI (Vectorlabs).  
 
Immunohistochemistry for activated caspase-3 or p53-ser15 (murine homologue 
is serine 18) was performed overnight at room temperature after quenching endogenous 
peroxidase activity with 0.6% hydrogen peroxide in methanol. Immunoreactivity was 
visualized with a vasoactive intestinal peptide substrate kit (V.I.P.; Vector Labs) 
according to the manufacturer's directions after tissues were treated with biotinylated 
secondary antibody and avidin DH-biotinylated horseradish peroxidase-H complex 
(Vectastain Elite kit; Vector Labs). Sections were counterstained with 0.1% methyl green 
(Vector Labs), dehydrated, and mounted in DPX reagent. Nissl staining was performed 
after cryosections were allowed to dry at room temperature and was followed by 
dehydration in alcohol and xylene. Apoptotic cells were detected with ApopTag 
Fluorescein in situ apoptosis detection kit (Chemicon international) according to the 
manufacturer’s instructions. Quantitation of TUNEL, caspase-3, p53-ser15, ssDNA, or 
SOX2 positive cells was determined by counting positive signal from images equivalent 
in size and magnification between genotypes. Images were captured using an Axioskop 
2.0 microscope (Carl Zeiss) and a SPOT camera (Diagnostic Instruments, Inc).  
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3.3 Results 
 
 
3.3.1  Atr deficiency results in microcephaly and cerebellar 
dysgenesis 
 
In order to evaluate the specific role of ATR during neurogenesis, Atr
loxP/loxP
 mice 
were crossed onto the same Nestin-cre transgenic line used with the Lig4
loxP/loxP
 mice 
reported in Chapter 2. Atr
+/loxP
; Nestin-cre mice were healthy and identical to Atr
+/+
; 
Nestin-cre counterparts. Thus either Atr
+/+
; Nestin-cre or Atr
+/loxP
; Nestin-cre genotypes 
were used interchangeably as controls and will be referred to collectively as Atr
Ctrl
 for 
simplicity. Atr
loxP/loxP
 mice were also compared with Atr
+/+
; Nestin-cre or Atr
+/loxP
; 
Nestin-cre animals. Nestin-cre status had no noticeable effect upon Atr
+/+
 mice, in 
contrast to the report that Nestin-Cre expression can cause neurogenesis defects when 
highly expressed in neural progenitor cells (Forni et al., 2006). When Nestin-cre positive 
controls were not available, Atr
+/+
, Atr
+/loxP
, or Atr
loxP/loxP
 animals were used as controls  
as well. Preference was always given to mice containing the Nestin-cre transgenes, when 
available. Real-time PCR was used to gauge efficiency of excision of the floxed exon 44 
in E13.5 Atr
Nes-cre
 CNS compared to Atr
+/+
; Nestin-cre littermates. DNA extracted from 
the whole CNS of 3 separate Atr
Nes-cre
 embryos showed 60-80% deletion efficiency 
(Figure 3.4). In situ hybridization is currently underway to specifically determine which 
areas of the CNS do and do not express an Atr mRNA transcript.  
 
 Atr
Nes-cre 
animals were born at a frequency consistent with expected Mendelian 
ratios (data not shown), but died during early post-natal life. Typically Atr
Nes-cre
 animals 
did not survive beyond P7, however there were occasional animals that survived up to 
P10 or P11. (Two such mice were examined histologically and found to have a less 
severe phenotype than that of the typical Atr
Nes-cre
 animals described below. Presumably 
such older animals were expressing the Nestin-cre transgene at a lower than usual level.) 
Cause of death remains undetermined, but is suspected to be associated with malnutrition, 
possibly due to inability to efficiently swallow and retain milk.  
 
Atr
Nes-cre
 pups showed severe overall growth deficiency and had consistently 
smaller brains compared to littermate controls (Figure 3.5A-B). We attribute the small 
body size of Atr
Nes-cre
 animals, at least partially, to malnutrition based upon our 
observation that their stomachs did not contain milk, which was visible in control 
littermates. To determine if larger littermates were out-competing the Atr
Nes-cre 
animals, 
littermates were removed from the cage leaving only the Atr
Nes-cre 
pups with the mother. 
This had no effect upon feeding or survival. Attempts were also made to hand feed the 
animals using canine milk replacement formula. We chose canine formula as the dietary 
habits of dogs and mice seemed more similar than that of cats and mice; however we do 
not know if feline formula would have been more suitable. One mL syringes were used in 
our attempts to hand feed the Atr
Nes-cre
 pups. This endeavor was a failure, as the formula 
was immediately regurgitated. Thus we speculate that dysphagia contributed to 
malnourishment and ultimate lethality of post-natal Atr
Nes-cre
 mice. 
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Figure 3.4 Nestin-cre mediated deletion efficiency of floxed Atr region in E13.5 
Atr
Nes-cre
 CNS. 
Real-time PCR was used to ascertain deletion efficiency of exon 44 in the Atr
Nes-cre
 E13.5 
CNS. Results for exon 44 were normalized to those for exon 29. 
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Figure 3.5 Atr
Nes-cre
 mice showed severe growth defects accompanied by 
microcephaly and neurogenesis defects.  
(A) P6 Atr
Ctrl
 and Atr
Nes-cre
 littermates show significant size difference, with Atr
Nes-cre
 
animals being ~50% smaller than controls. (B) Atr
Nes-cre
 and Atr
Ctrl 
brains were collected 
from P6 littermates. Atr
Nes-cre
 mice have significantly smaller brains than Atr
Ctrl
 mice. (C) 
Nissl stained sections revealed structural abnormalities in the Atr
Nes-cre
 olfactory bulb 
(OB), corpus callosum (CC), rostral migratory stream (RMS), and cerebellum (Cer) in 
comparison to Atr
Ctrl
 (a-b). Immunostaining against calbindin D28K revealed disruption 
of Purkinje cell layer (PCL) and decreased cellular density of the internal granule layer 
(IGL) in Atr
Nes-cre
 animals (c,d). Magnification of Nissl stained panels is 15x. 
Magnification of calbindin-stained sections is 100x. 
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The cerebellum was most dramatically affected by Atr loss as manifested by lack 
of foliation and mislocalization of calbindin-positive Purkinje cells (Figure 3.5C c-d), 
consistent with defective granule cell generation as described in other mouse models and 
reminiscent of the phenotype described in the Nbn
f6/f6
; Nestin-cre mouse in which Nbs1 is 
conditionally deleted (Ben-Arie et al., 1997; Frappart et al., 2005; Jensen et al., 2002). 
Nissl staining revealed structural abnormalities in the forebrain of Atr
Nes-cre
 pups as well. 
Most notably, decreased cellularity of the corpus callosum was frequently observed and 
the rostral migratory stream (RMS) seemed largely nonexistent in sagittal sections 
(Figure 3.5C a-b). The RMS is comprised of progenitor cells that originate in the dorsal 
wall of the lateral ventricle, commonly referred to as the ventricular zone (VZ), and 
possibly in the ganglionic eminence (GE), then migrate to the olfactory bulb where they 
mature into inhibitory interneurons (Corbin et al., 2008; Lledo et al., 2008). Nissl stain 
was used on coronal sections of P5 Atr
Ctrl 
and Atr
Nes-cre 
olfactory bulb to confirm loss of 
the proliferating cells that comprise the RMS and resultant structural malformation. The 
olfactory bulb is a layered structure comprised of different cells types. In Atr
Nes-cre
 pups, 
the glomerular layer (GL), the external plexiform layer (EPL), and the mitral cell layer 
(MCL) appeared largely normal though cellularity seemed decreased. However, the 
internal plexiform layer (IPL) and granule cell layer (GCL) were rather undeveloped 
(Figure 3.6 upper panels). Consistent with the sparse population of the IPL and GCL, 
the RMS was nearly non-existent at age P5 in the Atr
Nes-cre
 animals (Figure 3.6 lower 
panels). Cellularity appeared drastically decreased throughout the cerebral cortex (CTX) 
and the corpus callosum (CC) as well (Figure 3.7). 
 
 
3.3.2 Atr loss was associated with increased DNA damage and p53-
dependent apoptosis in the developing brain 
 
Beginning at E13.5, DNA damage, as assessed by immunostaining against "-
H2AX, was apparent in the EGL and GE. This was not a surprising finding, as we 
predicted damage would be sustained in proliferating cells and lead to cell cycle arrest 
and/or apoptosis, based upon the report that ATR loss leads to H2AX phosphorylation 
upon replication stalling in MEFs (Brown & Baltimore, 2003). The surprising finding 
was that "-H2AX foci were not uniformly present in all proliferating areas of the Atr
Nes-cre
 
brain. At E13.5, the EGL contained a subset of cells that were positive for "-H2AX, 
whereas the RL did not exhibit signs of DNA damage though it is comprised of 
proliferating cells. Indeed it was not until E16.5 that any "-H2AX was detected in the RL 
of Atr
Nes-cre
 mice (Figure 3.8).  
 
 The GE also exhibited substantial damage by E13.5 based upon immunostaining 
against "-H2AX (data not shown). Between E13.5 and E17.5, the level of damage in the 
GE increases with a peak around E16.5/E17.5 and a trough at E18.5 (Figure 3.9). The 
GE provides inhibitory interneurons to the cortex, the olfactory bulb via the RMS, and 
the striatum. Different subtypes of inhibitory interneurons arise from spatially distinct 
progenitor cell populations of the ganglionic eminence (Corbin et al., 2008; Wonders & 
Anderson, 2005). The medial ganglionic eminence appears to be the main source of 
somatostatin-positive interneurons and of parvalbumin-positive cortical interneurons. 
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Figure 3.6 Nissl stained coronal sections of the P5 Atr
Nes-cre
 olfactory bulb and rostral 
migratory stream. 
Coronal sections of the olfactory bulb (upper panels) and the rostro-ventral forebrain 
(lower panels) revealed severe depletion of the rostral migratory stream (RMS) and 
decreased cellularity in the internal plexiform layer (IPL) and granule cell layer (GCL) of 
the Atr
Nes-cre 
mice (right) in comparison to controls (left). The mitral cell layer (MCL) and 
the external plexiform layer (EPL) appeared similar to those of the Atr
Ctrl
 samples though 
the glomerular layer (GL) seems sparse in Atr
Nes-cre
 samples. Magnification is 100x.
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Figure 3.7 P5 Atr
Nes-cre
 forebrain stained for Nissl substance.
Sagittal sections prepared from P5 Atr
Ctrl
 and Atr
Nes-cre
 brain samples were stained with 
Nissl. Though cellularity appears decreased in most regions, overall structure is largely 
preserved in the Atr
Nes-cre
 samples. The corpus callosum (CC) showed dramatically 
decreased cellularity. Sections progress lateral to medial from top to bottom. Other 
abbreviations: cortex (CTX), globus pallidus (GP), caudate putamen (CP). Magnification 
is 100x. 
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Figure 3.8 Pattern of "-H2AX foci in the Atr
Nes-cre
 cerebellum. 
(A-B) E13.5 Atr
Nes-cre
 samples showed increased immunostaining against "-H2AX (red) 
in the external granule cell layer (EGL) compared to Atr
Ctrl
 littermates, but not in other 
regions of the developing cerebellum. (C-D) At E15.5, there was no substantial indication 
of DNA damage in the rhombic lip (RL) of Atr
Nes-cre
 samples in comparison to controls, 
but some damage had arisen in the internal granule cell layer (IGL). (E-F) At E16.5, the 
RL showed increased "-H2AX signal and the IGL had sustained more damage than at 
E15.5 in Atr
Nes-cre
 samples. Atr
Ctrl
 samples did not show appreciable "-H2AX signal at 
any stage (A, C, E). N is at least 2 for each genotype at each embryonic stage. 
Magnification is 200x. Nuclei were stained with DAPI (blue).    
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Figure 3.9 Pattern of "-H2AX in the ganglionic eminence and lateral ventricular 
zone of embryonic Atr
Nes-cre
 mice. 
(A,B) At E15.5, the ganglionic eminence (GE) showed substantial "-H2AX (red) signal. 
Atr
Nes-cre
 animals did not show DNA damage in the cortical ventricular zone (VZ) until 
E16.5 (C,D) and by E18.5 "-H2AX was shown throughout the entire cortical VZ and the 
outer $ tubulin III (TUJ1) (green) negative region of the GE (E,F). Magnification is 200x. 
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Production of calretinin-positive interneurons has been attributed to the caudal ganglionic 
eminence, while the lateral ganglionic eminence generates specific subclasses of 
interneurons in the striatum, olfactory bulb, piriform cortex, and amygdala (Corbin et al., 
2008). For the sake of simplicity, the GE will be considered as a whole with no emphasis 
placed upon its divisions in this study. However, subsequent work will be required to 
determine if loss of Atr in the GE specifically affects the subtypes of interneurons in the 
forebrain.  
 
 The proliferative dorsal wall of the lateral ventricle gives rise to a vast variety of 
neural precursors that will produce the excitatory projection neurons of the cerebral 
cortex (Corbin et al., 2008). We predicted that the Atr
Nes-cre
 animals would begin to show 
severe damage in the VZ relatively early during embryogenesis, similar to that seen in the 
EGL at E13.5. However, it was not until E16.5 that significant damage was detected in 
the dorsal VZ (Figure 3.9 and 3.10). In line with the presence of DNA damage and 
defective neurogenesis, apoptosis was found to be a prominent occurrence during 
neurogenesis in Atr
Nes-cre 
samples. The pattern of cell death was somewhat similar to that 
of "-H2AX foci. Despite the presence of "-H2AX and 53BP1 foci in the E13.5 Atr
Nes-cre
 
EGL, apoptosis was not detected using either TUNEL assay or immunostaining against 
ssDNA in the E13.5 cerebellum (data not shown). The Atr
Nes-cre
 GE did contain many 
apoptotic cells, as predicted by the presence of substantial DNA damage in that area at 
E13.5 (data not shown).  
 
 The presence of "-H2AX is not necessarily an indicator of apoptosis, as 
demonstrated by the occurrence of DNA damage foci in the adult Lig4
Nes-cre
 which did 
not exhibit apoptosis based upon TUNEL assay (data not shown). However, DNA 
damage does lead to apoptosis such that the two phenomena are often correlated. 
Immunostaining against ssDNA (data not shown) and TUNEL assay demonstrated this in 
Atr
Ctrl
 and Atr
Nes-cre
 in which apoptosis did largely mirror the pattern of "-H2AX observed 
at E15.5 and onward. In the E15.5 Atr
Nes-cre
 cerebellum, most cell death was observed in 
the EGL with some TUNEL-positive cells in the RL (Figure 3.11 upper panels). The 
level of cell death increased in the E16.5 cerebellum compared to that of the E15.5 Atr
Nes-
cre
 samples (Figure 3.11 middle panels). By E18.5, cell death was seen primarily in the 
IGL of the Atr
Nes-cre
 cerebellum (Figure 3.11 lower panels). This pattern of cell death 
was relatively consistent with the pattern of DNA damage foci described above. At 
E18.5, the Atr
Nes-cre
 cerebellum showed "-H2AX signal only in the IGL, similar to the 
pattern of cell death (data not shown). The same proved true of the GE and VZ in that the 
occurrence of apoptosis largely correlated with the presence of DNA damage (Figure 
3.12 and 3.13).  
 
 After DNA damage, both ATM and ATR phosphorylate p53 on serine 15 (serine 
18 in mice) (Canman et al., 1998; Cimprich & Cortez, 2008; Tibbetts et al., 1999). As a 
critical part of the DNA damage response, p53 can activate either cell cycle arrest or 
apoptosis (Vousden & Lu, 2002). In order to better understand the nature of apoptotic 
induction in Atr
Nes-cre
 mice, immunostaining against p53-phosphoserine 15 was used. 
Phosphorylation of p53-serine 15 was detected in the cerebellum, GE and cortical 
ventricular zone (Figure 3.14) and mimicked the patterns of apoptosis and DNA damage  
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Figure 3.10 Pattern of "-H2AX formation in the developing Atr
Nes-cre
 cortex. 
(A, B)The ventricular zone of the Atr
Nes-cre
 neopallial cortex showed only a slight increase 
in "-H2AX (red) immunostaining as compared to Atr
Ctrl 
at E15.5. (C-F) From E16.5 to 
E18.5, DNA damage became much more prominent in this region. Labeling against $ 
tubulin III (TUJ1) (green) delineated the border between the VZ and the more 
differentiated sub-ventricular zone. Magnification is 200x. 
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Figure 3.11 Pattern of cell death in the Atr
Nes-cre
 cerebellum. 
TUNEL labeling (green) was used to detect apoptosis in the embryonic Atr
Nes-cre
 
cerebellum. At E15.5, Atr
Nes-cre
 samples showed increased apoptosis primarily in the 
external granule layer (EGL). Cell death was also apparent in the rhombic lip (RL) in 
E15.5 Atr
Nes-cre
 samples (upper panels). E16.5 Atr
Nes-cre
 samples showed greater presence 
of cell death in all regions of the cerebellum, except the dorsal wall of the fourth ventricle 
(VZ) (middle panels). At E18.5, the RL is diminished and the EGL is fully formed. 
Lower panels show anterior cerebella of E18.5 Atr
Ctrl
 (left) and Atr
Nes-cre
 (right). 
Apoptosis is mainly visible in the IGL. Magnification is 200x. Nuclei were stained with 
propidium iodide (red). Arrows indicate TUNEL-positive cells. 
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Figure 3.12 Pattern of cell death in lateral ventricular zone and ganglionic eminence 
of Atr
Nes-cre
 embryos. 
At E15.5, the ganglionic eminence (GE) showed substantial TUNEL signal (green) 
(upper panels). Atr
Nes-cre
 animals did not show substantial cell death in the cortical 
ventricular zone (VZ) until E16.5 (middle panels) and by E18.5 TUNEL positive cells 
were visible throughout the entire cortical VZ and the outer region of the GE (lower 
panels). Magnification is 200x. Nuclei were stained with propidium iodide (red). Lateral 
ventricle is abbreviated LV. 
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Figure 3.13 Pattern of cell death in the ventricular zone of the embryonic Atr
Nes-cre
 
cortex. 
The ventricular zone of the Atr
Nes-cre
 neopallial cortex showed only a slight increase in 
TUNEL signal (green) as compared to Atr
Ctrl 
at E15.5 (upper panels). From E16.5 to 
E18.5, DNA damage became much more prominent in this region (middle and lower 
panels). Magnification is 200x. Nuclei were stained with propidium iodide (red). 
Abbreviations: ventricular zone (VZ), sub-ventricular zone (SVZ), intermediate zone 
(IZ), cortical plate (CP). 
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Figure 3.14 Immunostaining against p53-phosphoserine 18 in E16.5 Atr
Ctrl
 and 
Atr
Nes-cre
 samples. 
Activation of p53 correlated with the incidence of "-H2AX appearance and apoptosis. (A, 
B) At E16.5, the Atr
Nes-cre 
external granule layer (EGL) and rhombic lip (RL) showed up-
regulation of p53 that was not observed in Atr
Ctrl
 animals. (C-F) The same was true in the 
ganglionic eminence (GE) and the ventricular zone (VZ). The intermediate zone (IZ) and 
the cortical plate (CP) were negative for p53 induction. Arrows indicate p53 ser 18- 
positive cells.  
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observed during development of Atr
Nes-cre
 embryos (Figures 3.8-3.13). Atr
Nes-cre
 mice 
were crossed onto a p53-null background to determine if p53 induction caused 
microcephaly associated with ATR-Seckel syndrome (Personal communication with Dr. 
Pierre-Olivier Frappart, March 6, 2008). Dr. Frappart observed full rescue of apoptosis in 
all affected regions of the Atr
Nes-cre
 E15.5 animals in the p53
-/-
 genetic background, based 
upon TUNEL labeling and immunostaining against active caspase-3 (Figure 3.15Ca-f, 
m-r). However, P5 Atr
Nes-cre
p53
-/-
 animals did not exhibit substantial rescue of 
neuropathology associated with Atr loss (Figure 3.15A-B). Furthermore, Dr. Frappart’s 
data showed no defect in proliferation of granule cell progenitors in the E15.5 Atr
Nes-cre
 or 
Atr
Nes-cre
 p53
-/-
 EGL as indicated by BrdU labeling of S-phase cells (Figure 3.15Cs-u). 
The same was true for the GE (Figure 3.15Cv-x). These data indicate that though p53-
dependent apoptosis is a feature of the Atr
Nes-cre
 phenotype, it does not significantly 
contribute to the gross pathological state of the brain. Furthermore, p53-induced cell 
cycle arrest is not a significant contributing factor to the microcephaly and aberrant 
neurogenesis that is characteristic of the Atr
Nes-cre
 genotype and hence ATR-SS. These 
results are currently being independently confirmed. 
 
 
3.3.3 Atr deficiency results in depletion of proliferating cell 
populations during neurogenesis 
 
 Having established the neurogenic defects that result from Atr deficiency in the 
Atr
Nes-cre
 model were not due to p53 signaling, embryonic studies were necessary to 
determine the events responsible for the phenotype. It was clear based upon Dr. 
Frappart’s report of the Atr
Nes-cre
 p53
-/-
 mice that apoptosis as detected by TUNEL and 
active-caspase 3 was not the cause of defective neurogenesis, as p53-deficiency rescued 
apoptosis without correcting neural malformations. Up to E15.5, no proliferation defect 
was observed in any area of the Atr
Nes-cre
 CNS when compared to controls (Figure 3.15C 
and data not shown). At E16.5 however, a dramatic decrease in PCNA and Ki67 positive 
cells was apparent in the EGL. The rhombic lip did not appear significantly different in 
Atr
Nes-cre
 samples as compared to controls (Figure 3.16). It was surprising that the RL 
was not more dramatically affected by Atr inactivation, as it is comprised of proliferating 
neural precursors. To determine if the Atr
Nes-cre
 genotype affected the proliferating neural 
precursors of the RL and the fourth ventricle (V4), immunostaining against SOX2 was 
performed. SOX 2 is a transcription factor required for proliferation and maintenance of 
neural stem cells (Nicolis, 2007; Zappone et al., 2000). The RL remains prominent until 
about E17.5, at which time the EGL appears highly developed and the RL is largely 
diminished. Despite the presence of "-H2AX and apoptotic cells in the E16.5 Atr
Nes-cre
 
RL, there was no decrease in the number of either SOX2-positive or PCNA- positive 
cells (Figure 3.16-3.17). No notable differences in either SOX2 expression or expression 
of the proliferation markers PCNA and Ki67 were observed in the forebrain until later 
stages of embryonic development. Proliferation of the lateral ventricular zone and RMS 
appeared largely unaffected in E16.5 and E17.5 Atr
Nes-cre
 samples (data not shown). At 
E18.5 there was a drastic difference in PCNA status between Atr
Ctrl
 and Atr
Nes-cre
 
ganglionic eminence (GE) and the lateral ventricular zone (Figure 3.18A-E). A more 
subtle decrease in the number of proliferating cells in the OB was observed (Figure  
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Figure 3.15 Apoptosis was rescued in Atr
Nes-cre
 p53
-/-
 animals, but neuropathology 
was not affected by p53 loss in P5 Atr
Nes-cre
 mice. 
(A) Atr
Nes-cre
 p53
+/-
 mice showed significantly increased weight in comparison to age-
matched Atr
Nes-cre
 littermates (P value = 0.0063). The Atr
Nes-cre
 p53
-/-
 genotype also 
positively affected Atr
Nes-cre
 body weight (P value = 0.0099). Neither the Atr
Nes-cre
 p53
+/-
 
nor Atr
Nes-cre
 p53
-/-
 genotype showed a significant difference in brain size compared with 
age-matched Atr
Nes-cre
 littermates (P values are 0.0730 and 0.1631, respectively). (B) The 
Atr
Nes-cre
 p53
-/- 
phenotype was indistinguishable from that of Atr
Nes-cre
 in terms of size (a-
c) or fine structure of the brain based on H&E stain (d-i) or immunostaining against 
calbindin D18K to label cerebellar Purkinje cells (j-o). (C) Sections were collected from 
E15.5 embryos and evaluated for differences in DNA damage signaling between the 
Atr
Nes-cre
 and Atr
Nes-cre
 p53
-/-
 samples. The p53
-/-
 background rescued apoptosis based on 
TUNEL labeling (a-f) and immunostaining against active-caspase 3 (m-r). 
Immunostaining against "-H2AX showed persistent DNA damage in Atr
Nes-cre
 p53
-/-
  
embryos (g-l). BrdU labeling revealed no impact of either the Atr
Nes-cre
 or Atr
Nes-cre
 p53
-/-
 
upon proliferation at E15.5 (s-x). Immunostaining against p53 confirmed its stabilization 
in Atr
Nes-cre
 samples and showed its inactivation in Atr
Nes-cre
 p53
-/-
 samples (y-&). Personal 
communication with Dr. Pierre-Olivier Frappart, March 6, 2008. 
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Figure 3.16 Proliferation of the EGL in the E16.5 Atr
Nes-cre
 cerebellum is decreased. 
(A) Immunostaining against PCNA (upper panels) and Ki67 (lower panels) was used to 
assess the number of proliferating cells in the E16.5 Atr
Ctrl
 (left) and Atr
Nes-cre
 (right) 
cerebella. (B) The total number of PCNA-positive cells was counted from images 
representative of those shown in A. (C) The total number of Ki67-positive cells was 
counted from images representative of those shown in A. Multiple sections from each 
sample were analyzed. Three animals per genotype were analyzed. P value was derived 
from an unpaired t-test. Photomicrographs were captured at 200x magnification. 
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Figure 3.17 The rhombic lip is largely unaffected in Atr
Nes-cre
 embryos. 
Immunostaining against SOX2 (red) and $ tubulin III (TUJ1) (green) was used to 
analyzed the effects of the Atr
Nes-cre
 genotype on cerebellar precursor cells in E15.5 (A,B) 
and E16.5 (E, F) samples. Immunostaining of E15.5 Atr
Ctrl
 and Atr
Nes-cre
 samples against 
PCNA (green) indicated no difference in proliferation in the RL at this stage (C, D). 
Similarly, there was no change in the number of PCNA-positive cells (red) in the RL of 
Atr
Ctrl
 and Atr
Nes-cre
 samples at E16.5 (G, H). Quantitation of these results (as described in 
Figure 3.14) was performed for E16.5 samples (right hand panels). Photomicrographs 
were captured at 200x magnification. 
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Figure 3.18 Immunostaining against PCNA in E18.5 Atr
Nes-cre
 forebrain.  
Immunostaining against PCNA (red) showed decreased proliferation in the Atr
Nes-cre
 
forebrain at E18.5. Proliferating regions such as the ganglionic eminence (GE), the walls 
of the lateral ventricle (VZ), the subventricular zone (SVZ) and the rostral migratory 
stream of the olfactory bulb (OB) were affected. Nuclei were stained with DAPI (blue). 
Magnification is 200x. The lateral ventricle is abbreviated LV. 
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3.18E-F). Immunostaining against Ki67 was consistent with those findings (data not 
shown). Immunostaining against PCNA revealed substantial depletion of proliferating 
cells in the lateral ventricular zone of P5 Atr
Nes-cre
 animals, in comparison to littermate 
controls (Figure 3.19A-B). The Atr
Nes-cre
 cerebellar EGL also had significantly fewer 
proliferating cells during post-natal life, consistent with the embryonic findings. This was 
particularly true in more lateral sections (Figure 3.19C-D) and less dramatic (though 
obvious compared to Atr
Ctrl
) in medial regions that displayed a relatively thicker EGL 
with more proliferating cells (Figure 3.19E-F). The Atr
Nes-cre
 dentate gyrus showed only 
a marginal decrease in PCNA positive cells compared to that of Atr
Ctrl
 mice (data not 
shown). We therefore attribute the neurogenesis defects found in Atr
Nes-cre 
to reduced 
proliferation, rather than apoptosis, in the developing nervous system. 
 
 
3.3.4 Atm and Atm functions are not obviously redundant in the 
developing brain 
  
 The induction of p53-dependant cell death in proliferating regions of the Atr
Nes-cre
 
embryonic brain indicated that either ATR signaling is not required for p53 activity in 
these regions or that ATM is responsible for p53 activation in proliferating neural 
precursors in the absence of ATR. Alternatively there may be another gene involved in  
p53 regulation during the DNA damage response.  
 
 To genetically delineate the in vivo distinctions between ATM and ATR activity 
during neurogenesis, Atm was conditionally deleted in the CNS through generation of 
Atm
loxP/loxP
 mice which were then crossed with Atr
+/loxP
; Nestin-cre mice to produce 
Atr
loxP/loxP
; Atm
loxP/loxP
; Nestin-cre (Atr
Nes-cre
 Atm
Nes-
 
cre
) double conditional knock-out 
animals. The conditional Atm allele was chosen for this study in order to circumvent 
possible affects outside the nervous system as well as to promote more efficient breeding 
strategies (germline Atm
-/-
 animals are sterile). Atm
Nes-cre
 mice had not been previously 
characterized, thus it was necessary to first confirm the ablation of Atm activity in the 
nervous system. At the time these animals were generated, there was not a reliable 
antibody against ATM suitable for use in murine tissue. So, we used real-time PCR to 
confirm excision of the DNA encoding the targeted exon and assessed the effects of the 
Atm
Nes-cre
 genotype on IR-induced apoptosis in the post-natal cerebellum. DNA extracted 
from cryosections of E15.5 Atr
Nes-cre
 Atm
Nes-cre
 brains was used for real-time PCR analysis 
of excision efficiency for exon 58, which is the floxed exon of the Atm conditional 
mouse model used in this study. In comparison to one Atr
+/loxP
 Atm
+/loxP
; Nestin-cre 
(Atr
+/Nes-cre
 Atm
+/Nes-cre
) three Atr
Nes-cre
 Atm
Nes-cre
 showed approximately 70-80% deletion 
efficiency (Figure 3.20A). To confirm adequate decrease of Atm activity, P6 Atm
Ctrl
 and 
Atm
Nes-cre
 animals were subjected to 18 Gy IR and allowed to recover for 18 hours prior 
to sacrifice. TUNEL assay revealed abrogated apoptosis in the EGL and dentate gyrus 
(data not shown) of the Atm
Nes-cre 
animals (Figure 3.20B). Untreated Atr
Ctrl
 Atm
Nes-cre
 
samples were identical to untreated Atr
Ctrl
 Atm
Ctrl 
littermates in every aspect analyzed. 
Atr
Ctrl
 Atm
Nes-cre
 controls have been excluded from some figures for more efficient use of 
space. 
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Figure 3.19 Immunostaining against PCNA in P5 Atr
Ctrl 
and Atr
Nes-cre
 sagittal sections 
of cerebellum and forebrain.  
Immunostaining against PCNA (red) was applied to brain sections collected from Atr
Ctrl
 
and Atr
Nes-cre
 mice at P5. Similar to results obtained at E18.5 (Figure 3.16), the walls of 
the lateral ventricle showed drastically decreased PCNA positivity in the developing 
cortex and basal ganglia of Atr
Nes-cre
 samples (A, B). The EGL of the lateral cerebellum 
was nearly non-existent and showed almost no PCNA-positive cells in the Atr
Nes-cre 
samples, in stark contrast to that of age-matched Atr
Ctrl
 animals (C, D). The EGL of the 
medial cerebellum was thicker than in the lateral sections, but still showed decreased 
presence of PCNA-positive cells compared to controls (E, F). Nuclei were stained with 
DAPI (blue). Magnification is 200x in panels A and B, 100x in C-F. 
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Figure 3.20 Efficient Nestin-cre mediated excision of Atm exon 58 and confirmation 
of genotype consistent with Atm
-/-
 mice. 
(A) Real-time PCR was used to ascertain deletion efficiency of exon 58 in the Atm
Nes-cre
 
E15.5 CNS. Results for exon 58 were normalized to those for exon 52. (B) P6 Atm
Ctrl 
and 
Atm
Nes-cre
 mice were treated with 18 Gy of IR or mock irradiated and allowed a recovery 
period of 18 hours. TUNEL assay (green) and immunostaining against $ tubulin III 
(TUJ1) (red) were performed. Nuclei were stained with DAPI (blue). Magnification is 
200x. 
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 Atr
Nes-cre
 Atm
Nes-cre
 mice were born at the expected Mendelian ratio (data not 
shown), and were phenotypically indistinguishable from Atr
Nes-cre
 littermates (Figure 
3.21). No difference was observed in either the gross appearance or histological features 
between the Atr
Nes-cre
Atm
Ctrl
 and Atr
Nes-cre
 Atm
Nes-cre
 brains (Figure 3.21A). Neither brain 
nor body weights showed any significant difference (Figure 3.21B). Lifespan and 
capacity to feed properly were similarly unaffected in Atr
Nes-cre
 Atm
Nes-cre
 pups compared 
to Atr
Nes-cre 
Atm
Ctrl
 littermates (data not shown). Immunostaining against calbindin-D28K 
showed the cerebellar abnormalities typical of Atr
Nes-cre
 mice to be unaffected by Atm-
deficiency (Figure 3.21C). Other morphologic abnormalities described in section 3.3.1 
for Atr
Nes-cre
 mice were identical to those found in Atr
Nes-cre
 Atm
Nes-cre
 animals (data not 
shown). We compared the endogenous DNA damage response between Atr
Nes-cre
 Atm
Ctrl
 
and Atr
Nes-cre
 Atm
Nes-cre
 littermates as well. Immunostaining against total p53 revealed its 
stabilization in the E16.5 EGL of both Atr
Nes-cre
 Atm
Ctrl
 and Atr
Nes-cre
 Atm
Nes-cre
 samples, 
while no p53-positive cells were observed in Atr
Ctrl
 Atm
Ctrl
 and Atr
Ctrl
 Atm
Nes-cre
 samples 
(Figure 3.22A-C and data not shown). Phosphorylation of p53 on serine 18 observed in 
the EGL of Atr
Nes-cre
 Atm
Ctrl
 embryos was entirely abrogated by Atm-deficiency (Figure 
3.22D-F). This leads us to speculate that the p53-phosphoserine 18 positive cells 
observed in the embryonic EGL of Atr
Nes-cre
 mice likely reflect granule precursor cells 
that acquired damage during later stages of replication, but did not initiate the DSB 
response until after exiting the cell cycle. However, further experiments would be 
required to prove this to be the case, rather than Atm induction in replicating neural 
precursors. TUNEL assay and immunostaining against Ki67 were used to determine if 
Atm loss affected either apoptosis or proliferation in Atr
Nes-cre
 embryos. At E16.5, no 
significant difference was observed in the levels of either apoptosis or proliferation 
between Atr
Nes-cre
 Atm
Ctrl
 and Atr
Nes-cre
 Atm
Nes-cre 
animals, as demonstrated in the EGL 
(Figure 3.22G-L). Similarly, no differences in proliferation or apoptosis were observed 
in the RL, cortex, ganglionic eminence, or other areas in the Atr
Nes-cre 
Atm
Nes-cre
 nervous 
system when compared with age-matched Atr
Nes-cre
 Atm
Ctrl
 embryos. Phosphorylation of 
H2AX on ser 139 was also similar between Atr
Nes-cre
 Atm
Nes-cre
 and Atr
Nes-cre
 Atm
Ctrl
 
embryos (data not shown). These data suggest that ATR and ATM do not function 
redundantly in the developing nervous system, but may cooperate indirectly to ensure 
genomic stability. 
 
 
3.4  Discussion 
 
 ATM and ATR are structurally and functionally similar signaling kinases that 
share many overlapping substrates and are involved in the DNA damage response. 
However, the physiologic requirements of these genes are quite distinct as ATR-
deficiency is associated with developmental microcephaly and ATM inactivation leads to 
the neurodegenerative syndrome A-T (Cimprich & Cortez, 2008). Activation of ATR 
occurs through recognition of RPA-coated ssDNA regions and interaction with TopBP1 
and ATRIP; whereas current knowledge of ATM activation revolves around its being 
recruited to DSB sites and undergoing autophosphorylation events that are partially  
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Figure 3.21 Atr
Nes-cre
 Atm
Nes-cre
 mice are indistinguishable from Atr
Nes-cre
 littermates. 
(A) Measurement of the Atm
Nes-cre
 mutation towards Atr
Nes-Cre
 brain size. (B) Brain and 
body weights were collected from sex-matched cohorts at P5. Error bars represent 
standard deviation. P value = 1 between the Atr
Nes-Cre
 Atm
Ctrl
 brain weights and the Atr
Nes-
Cre
Atm
Nes-cre
 brain weights. P value = 0.09228 (n =3) between the Atr
Nes-Cre
 Atm
Ctrl
 body 
weights and the Atr
Nes-Cre 
Atm
Nes-cre
 body weights. (C) Atr
Nes-cre
 Atm
Nes-cre
 cerebellar 
morphology was largely similar to that of Atr
Nes-cre
 Atm
Ctrl
 littermates, as shown by 
immunostaining against calbindin-D28K. Methyl green was used to counterstain nuclei. 
Magnification is 100x. 
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Figure 3.22 DNA damage signaling in the E16.5 Atr
Nes-cre
 Atm
Nes-cre
 EGL. 
(A-C) Immunostaining against p53 (purple) showed similar stabilization of total p53 in 
E16.5 Atr
Nes-cre
 Atm
Ctrl
 compared to Atr
Nes-cre
 Atm
Nes-cr e
 littermates. (D-E) Phosphorylation 
of p53 serine 18 (purple) was largely abrogated in Atr
Nes-cre
 Atm
Nes-cr e
 samples. (G-I) 
TUNEL assay showed that Atm-deficiency did not significantly block apoptosis in the 
Atr
Nes-cre
 Atm
Nes-cr e
 EGL, as cell death was similar to that observed in Atr
Nes-cre
 Atm
Ctrl
 
samples. (J-I) Immunostaining against Ki67 revealed no effect of Atm-deficiency on 
proliferation in the E16.5 EGL. Because cerebellar sections are not matched in this 
figure, no conclusions can be drawn regarding structural differences between any of the 
genotypes. No differences were observed between Atr
Ctrl
 Atm
Ctrl
 and Atr
Ctrl
Atm
Nes-cre
 
samples (data not shown). Magnification is 200x. 
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dependant upon the MRN complex (Mordes & Cortez, 2008; Mordes et al., 2008). For 
example, ATM-phosphoserine 1981 foci are largely reduced in Nbs1 mutant cells 
(Kitagawa et al., 2004). Phosphorylation of p53 at serine 15 is an integral component of 
the DNA damage response. It has been shown that ATM is an important mediator of p53 
induction both in vitro and in vivo (Banin et al., 1998; Canman et al., 1998; Kastan et al., 
1992; Khanna et al., 1998; Lavin, 2008). ATR function has also been linked to p53 
activity. Doxycycline induced overexpression of catalytically inactive ATR in human 
fibroblasts inhibited p53 phosphorylation on serines 15 and 37 (Tibbetts et al., 1999). 
Lenti-cre- infected ATR
flox/-
 fibroblasts showed reduced p53-serine 18 phosphorylation at 
later time points following IR, with ATM being responsible at earlier time points (Brown 
& Baltimore, 2003).  
 
 The Atr
Nes-cre
 phenotype provided insight into the nature of developmental delay 
and microcephaly associated with ATR-Seckel syndrome. Consistent with the known 
requirements of ATR in responding to replication stress and UV-induced DNA damage, 
DSBs associated with p53-dependant apoptosis were observed in areas of the developing 
Atr
Nes-cre
 brain that are largely populated by proliferating progenitor cells. Importantly, 
Atr-deficiency also led to a significant decrease in the number of proliferating cells in the 
forebrain and cerebellar EGL of Atr
Nes-cre
 embryos. Surprisingly, this affect was not 
observed in the rhombic lip, which is comprised of proliferating progenitor cells that 
generate the EGL. Additionally, it was surprising that the forebrain did not show the 
decrease in proliferation until E18.5. As the appearance of DSBs, apoptosis, and 
decreased number of proliferating progenitor cells coincided temporally, it seems likely 
that these effects of Atr loss result directly from DNA damage. The question that arises 
though is why it takes so long for that damage to appear anteriorly, and why the 
proliferating cells of the rhombic lip are not affected while the EGL shows such a 
pronounced defect.  
 
 Parallel studies are currently underway in a TopBP1 conditional knock-out in 
which the rhombic lip is dramatically affected by E13.5 and there is clear reduction in the 
SOX2-positive progenitors of both the rhombic lip and the dorsal wall of V4 that 
produces progenitor cells which will generate cells such as cerebellar interneurons. We 
hope that through extensive comparison of the TopBP1 mutant and the Atr
Nes-cre
 mice, the 
relationship between ATR and TopBP1and the specific requirements for ATR activity in 
different cell types can be determined. Of course, we cannot neglect the possibility that 
Cre activity is less efficient in some cell types of the Atr
Nes-cre
 embryos (despite the 
phenotype of the TopBP1 mutants crossed with the same Nestin-cre line). There is also 
the question as to how long Atr protein produced prior to gene deletion remains stable in 
these cell types. There is not currently a suitable antibody against Atr with which we can 
directly assess protein expression, so in situ hybridization experiments are underway to 
better evaluate these issues. Germline deletion of Atr leads to lethality by E7.5, 
suggesting that Atr is depleted within 24 hours after maternal supply is exhausted.  
 
 I have shown here that p53 is stabilized in the Atr-deficient nervous system and is 
responsible for apoptosis of cells in the EGL and VZ in response to DNA damage 
occurring after Atr loss. A subset of cells in the cerebellum and other developing regions 
71 
 
showed Atm-dependant phosphorylation of p53 serine 18 in Atr
Nes-cre
 embryos. Induction 
of p53 was correlated with apoptosis in the developing Atr
Nes-cre
 brain. In Atr
Nes-cre
 Atm
Nes-
cre
 embryos, p53 serine18 phosphorylation was severely attenuated, but apoptosis 
occurred at a level consistent with that of Atr
Nes-cre
 Atm
Ctrl
 samples. Apoptosis observed in 
the embryonic Atr
Nes-cre
 brain is p53-dependant however, as cell death was significantly 
abrogated in Atr
Nes-cre 
p53
-/-
 animals. We speculate that the cells exhibiting Atm-
dependant p53 serine18 phosphorylation had recently exited the cell cycle carrying 
damage accrued during replication, which resulted in death. However, experiments (such 
as co-labeling with TUNEL and antibodies against cell cycle markers or doublecortin, 
which marks post-mitotic, differentiating cells) have not been performed to determine if 
this is the case. This data also indicates a mechanism of DNA-damage induced p53 
stabilization that is independent of either Atr or Atm. Further work will be necessary to 
identify the factor(s) responsible for p53 induction in this situation. Possibilities include 
DNA-PKcs, which is another serine/threonine kinase similar to ATR and ATM, but so far 
has been characterized primarily as a part of the NHEJ repair process (Mahaney et al., 
2009). The role of DNA-PKcs in the nervous system is unclear.  
 
 Though ATR and ATM deficiency result in highly different neuropathologies, the 
possibility exists that there are still overlapping, redundant functions in the brain. ATR 
has been reported to function upstream of ATM. Fibroblasts derived from an ATR-Seckel 
syndrome individual showed defective ATM autophosphorylation on serine 1981 in 
response to either hydroxyurea-induced replication stress or UV-induced damage. 
Targeting ATR by siRNA was used to show normal ATM serine 1981 phosphorylation in 
response to IR (Myers & Cortez, 2006; Stiff et al., 2006). Alternatively, it has also been 
reported that ATM and NBS1 are required for full ATR-dependent phosphorylation of 
Chk1 during S and G2 phases of the cell cycle and for the formation of RPA-coated 
ssDNA, which is required for ATRIP mediated ATR recruitment (Jazayeri et al., 2006). 
Additionally, it has been reported that IR-induced Chk1 phosphorylation depends upon 
ATR, ATM, and MRE11, but HU and UV-induced Chk1 phosphorylation is ATR-
dependant and independent of ATM and MRE11. It has been shown also that ATM and 
MRE11 are required for formation of RPA-coated ssDNA (Myers & Cortez, 2006). 
While we have confirmed that Chk1 phosphorylation is indeed decreased in Atr
Nes-cre
 
brains (data not shown), we have not adequately addressed the contribution of Atm to 
Chk1 activation in vivo. These studies will be performed in the near future. Thus far, we 
have made no attempts to link MRN activity with Atr requirements in the nervous 
system. This is a highly compelling idea however, particularly given the similarities 
between ATR-Seckel syndrome and NBS. Further evidence of potential in vivo 
interactions between Nbs1 and Atr might also be hinted at in the phenotypic similarities 
between the conditional Nbs1 knock-out mice and the Atr
Nes-cre
 animals (Frappart et al., 
2005).  
 
In essence this study provides important insight into the pathology and etiology of 
ATR-Seckel syndrome. Based upon the microcephaly observed in the Atr
Nes-cre
 mice, we 
can extrapolate that ATR-Seckel syndrome is distinct from LIG4 syndrome in that it 
results from a combination of apoptosis and decreased proliferation (LIG4 syndrome 
appears to result strictly from apoptosis of newly post-mitotic cells in the developing 
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nervous system). The data shown here also indicate that while some Atm activity is 
induced in the Atr
Nes-cre
 brain (based upon p53 serine18 phosphorylation), Atr and Atm 
signaling pathways operate relatively independently in the developing nervous system. 
Furthermore, this study also provides a more detailed account of the specificity with 
which ATM and ATR are required to monitor genomic integrity during different stages 
of the cell cycle. 
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CHAPTER 4 DISCUSSION 
 
 
 Human syndromes in which the DNA damage response is defective can result in a 
variety of deleterious outcomes ranging from immunodeficiency, cancer predisposition, 
and infertility to profound neuropathology in the form of either degeneration or 
microcephaly. In particular, DNA damage poses a tremendous threat to the human 
nervous system, and when DNA repair mechanisms go awry the structural and functional 
integrity of the nervous system is at stake. Some diseases associated with DSB repair 
defects include ataxia-telangiectasia, Nijmegen breakage syndrome, ataxia-telangiectasia-
like disease, LIG4 syndrome, and ATR-Seckel syndrome. Additionally, defective single-
strand break repair mechanisms can also result in neurodegeneration similar to that of A-
T, but without any extraneural deficiencies. Examples of SSB repair deficiencies include 
ataxia with oculomotor apraxia 1 and spinocerebellar ataxia with axonal neuropathy. 
Similarly, mutations in components of the nucleotide excision repair pathway have been 
associated with the human syndromes xeroderma pigmentosum, Cockayne syndrome, 
and trichothiodystrophy, all of which present with varying degrees of neuropathology. 
While these conditions share many phenotypic similarities, each has its own distinct 
characteristics attributable to the gene and repair pathway affected (McKinnon, 2009). 
My work has sought to determine the signaling mechanisms that prevent the neurologic 
phenotypes of Nijmegen breakage syndrome, ataxia-telangiectasia, ataxia-telangiectasia 
like disease, and ATR-Seckel syndrome.  
 
 Atm-dependent apoptosis is necessary for elimination of newly post-mitotic, 
genotoxically stressed cells during neurogenesis (Herzog et al., 1998). The MRN 
complex is required for efficient ATM activity, and deficiencies in its components Mre11 
and Nbs1 result in immunodeficiency and radiation sensitivity similar to that seen in 
ATM-deficiency. However, NBS results in microcephaly while A-T and ATLD are 
characterized by neurodegeneration (Gatti & Swift, 1985; McKinnon, 2009; Stewart et 
al., 1999; van der Burgt et al., 1996). To determine why MRE11 and Nbs1 hypomorphic 
mutations result in different neuropathology, we compared the DNA damage response in 
the nervous systems of Mre11 and Nbs1 mutant mice with that of Atm
-/-
 mice. The 
Mre11
ATLD1/ATLD1
 and Nbs1
!B/!B
 mutant mice were designed to mimic the hypomorphic 
mutations identified in ATLD and NBS individuals, respectively (Theunissen et al., 2003; 
Williams et al., 2002). Despite decreased Atm autophosphorylation after DNA damage in 
the brains of both models, the Nbs1
!B/!B
 mutants showed an otherwise normal response to 
IR and endogenously occurring damage incurred in Nbs1, Lig4 double deficient mice. In 
contrast, Mre11
ATLD1/ATLD1 
mutants showed abrogated Atm-dependent, Chk2 and p53-
induced apoptosis of early post-mitotic neural cells in response to DSBs, similar to Atm
-/-
 
animals. We postulate that therein lays the distinction between ATLD and NBS 
neuropathology. 
 
 Similar to NBS, ATR-Seckel syndrome is characterized by microcephaly, but is 
associated with hypomorphic mutations in the ATR kinase (O'Driscoll et al., 2003). ATM 
and ATR share structural similarities as well as overlapping substrates, but respond to 
different forms of damage and undergo distinct modes of activation (Cimprich & Cortez, 
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2008; Mordes & Cortez, 2008). In vitro studies indicate direct cooperation and crosstalk 
in both function and interaction between these molecules (Cimprich & Cortez, 2008). 
Physiologically it is unclear how relevant these studies are, particularly because the 
neurologic consequences of ATM and ATR deficiencies are so distinct. Atr
-/-
 mice die 
very early in embryonic development (~E6-7.5), so a conditional Atr knock-out mouse 
model (Brown & Baltimore, 2000) was used to compare the requirements for these two 
kinases in the nervous system. Atr
Nes-cre
 mice were born at a Mendelian ratio, but 
typically died within the first week of life. Failure to thrive and severe neurogenesis 
defects were deemed to be the cause of death. Decreased proliferative capacity and p53-
dependant apoptosis caused depletion of the cerebellar EGL and abnormal forebrain 
development. These characteristics of the Atr
Nes-cre
 animals resemble those described in 
ATR-SS individuals, and were due primarily to proliferation failure of neural progenitors 
as p53-deficiency rescued apoptosis without dramatically impacting CNS morphology. 
Atm-deficiency did not impact the Atr
Nes-cre
 phenotype, though it did abrogate 
phosphorylation of p53-serine 18. Total p53 stabilization was not affected by Atm-loss 
and apoptosis was still detected in Atr
Nes-cre
 Atm
Nes-cre
 embryos. Thus, we conclude that 
while ATR and ATM likely cooperate in maintaining CNS integrity, the two proteins do 
not appear to directly interact genetically.  
 
 As a whole, this work provides deeper understanding into the requirements of 
ATR and the MRN complex in DSB signaling in the nervous system. Prior to these 
studies, most knowledge of ATR and MRN behavior was restricted to work using either 
primary fibroblasts or immortalized cell lines, neither of which are appropriate indicators 
of physiologic conditions in the nervous system. However, the mouse models used here 
have their limitations. While inactivating mutations in ATM and Mre11 cause 
neurodegeneration in humans, there is no obvious neuropathology in either Atm
-/-
 or 
Mre11
ATLD1/ATLD1
 mice. Similarly, Nbs1
!B/!B
 mice do not exhibit striking microcephaly 
though there is a minor, but statistically significant reduction in brain size. While the 
Atm, Mre11, and Nbs1 mutants used were designed to reflect specific mutations 
associated with the human counterparts, the Lig4
Nes-cre
 and Atr
Nes-cre
 mice reflect tissue-
specific deletion rather than the hypomorphic mutations reported in LIG4 syndrome and 
ATR-Seckel syndrome. Thus each mouse model used carries its own caveats in 
translating these data to the respective human conditions. However, it is only through 
animal studies that understanding of the neurologic impact of these diseases will ever be 
gained, and mice are currently the most accessible mammals in which to undertake 
genetic studies.  
 
 
4.1  Apoptosis Is Central to the Manifestation of Neuropathology    
Associated with DSB Repair Deficiencies 
 
 The DSB response normally results in either p53-dependant apoptosis or cell 
cycle arrest (Vousden & Lu, 2002). The proper balance between cellular death and 
proliferation is particularly important to ensure morphological and functional integrity of 
the nervous system. Atm
-/-
 mice fail to induce proper p53 signaling in response to either 
IR or endogenously occurring DNA damage, resulting in failure of genotoxically stressed 
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neural cells to undergo apoptosis (Chong et al., 2000; Gao et al., 2000; Herzog et al., 
1998; Lee et al., 2000; Sekiguchi et al., 2001). This failure to induce p53-dependant 
apoptosis is evidence that there is a DSB signaling deficit in the Atm
-/-
 brain, and it is 
postulated that cells which would otherwise have been eliminated from the developing 
nervous system become incorporated as mature neurons and later undergo degeneration 
due to genotoxic stress. It is unknown why mouse models fail to mimic the neurologic 
aspects of A-T. It is distinctly possible that there are genetic redundancies in the mouse 
brain that are lacking in humans, thus making mice more resistant to Atm loss. Another 
theory as to why Atm
-/-
 mice fail to recapitulate the cerebellar ataxia and degeneration 
characteristic of A-T is simply that timing of cerebellar maturation and lifespan do not 
accommodate the length of time required for such damage to accrue and manifest. It is 
typically not until at least 12-14 months of age that ataxia is noted in children with A-T 
(Gatti & Swift, 1985). Atm
-/- 
mice typically die of thymic lymphomas between 2-4 
months of age (Barlow et al., 1996; Elson et al., 1996), however those that evade tumors 
do not exhibit ataxia by 12 months of age. As with Atm
-/-
 mice, Mre11
ATLD1/ATLD1
 animals 
are a phenocopy of the extraneural characteristics of ATLD though there is no direct 
evidence of neurodegeneration or consequent ataxia (Theunissen et al., 2003). Because 
increased tumorigenesis is not observed in Mre11
ATLD1/ATLD1
 animals, they survive the 
normal murine lifespan up to 2 years, but fail to exhibit signs of neuropathology. Thus, 
the shorter lifespan of Atm
-/-
 mice is still an insufficient explanation as to why 
neurodegeneration is not observed. Furthermore, the accumulation of "-H2AX and 
53BP1 foci without consequent apoptosis in the adult Lig4
Nes-cre
 brain demonstrates that 
unlike immature neurons, mature neurons are highly impervious to DNA damage-
induced apoptosis. Cell cycle re-entry has been associated with death of post-mitotic 
neurons in neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s 
disease. It has been suggested that DNA damage promotes cell cycle re-entry of post-
mitotic Purkinje cells in human A-T tissue samples as well as in Atm
-/-
 and Atm
+/- 
mice 
(Yang & Herrup, 2005). In contrast, a separate study claims that Atm suppression 
protects post-mitotic cells from cell cycle re-entry and apoptosis in response to DNA 
damaging agents (Kruman et al., 2004). Most recently, Cdk5 has been implicated in 
activating Atm through phosphorylation of serine 794 in post-mitotic cultured granule 
cells. Interruption of Cdk5 signaling reportedly inhibits ATM activation (as indicated by 
serine 1981 autophosphorylation and phosphorylation of p53 on serine 18), and prevents 
DNA damage-induced cell cycle re-entry in cerebellar granule cells (Tian et al., 2009). 
Thus, there is conflicting data regarding whether or not ATM is required to induce 
neuronal cell death via cell cycle re-entry or whether ATM deficiency induces death 
through such a mechanism in mammalian tissues. Adequate studies of the relationship 
between ATM and Cdk5 have not been undertaken in vivo. Furthermore, the indication 
that Cdk5 is required for ATM activation indicates the need for further study in regard to 
how it and the MRN complex might cooperate in ATM activation, specifically in the 
nervous system. 
 
 Although the etiology of ataxia in either A-T or ATLD is not clear, both proteins 
are required for the DSB-induced death of early post-mitotic neural precursors through 
p53 signaling (Chong et al., 2000; Herzog et al., 1998; Lee et al., 2000; Lee et al., 2001; 
Sekiguchi et al., 2001; Shull et al., 2009). In contrast, normal p53 signaling and 
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subsequent apoptosis at least partially explain the microcephaly observed in LIG4 
syndrome and NBS. In the instance of LIG4 syndrome, mouse models provide a very 
clear cut case that unrepaired DSBs accumulate in post-mitotic neurons during 
embryogenesis and lead to Atm/Mre11/p53-dependent apoptosis that results in a drastic 
size reduction of the mature brain (Ferguson et al., 2000; Frank et al., 2000; Lee et al., 
2000; Sekiguchi et al., 2001; Shull et al., 2009). The nuances of Nbs1 function in the 
brain are less clear, as despite its interactions with Mre11 and Atm, the impact of 
disrupted Nbs1 activity in the nervous system does not overlap with that of either Mre11 
or Atm. In the Nbs1
!B/!B
 mutant, a DNA repair defect likely leads to increased cell death 
during neurogenesis and subsequent microcephaly. The Nbs1
!B
 allele lacks the 
FHA/BRCT N-terminal domains, similar to the mutations identified in NBS individuals 
(Williams et al., 2002). According to our data the Nbs1 N-terminus is thus not required 
for apoptotic induction through Atm (Shull et al., 2009). This is not entirely surprising as 
Atm binds Nbs1 through its C-terminus, and this interaction is required for efficient 
phosphorylation of Atm targets (Falck et al., 2005). However, the physiological 
significance of this interaction in relation to NBS pathology is complicated. Nbs1
!C/!C
 
mutant mice were indistinguishable from WT in terms of IR sensitivity and chromosomal 
stability (Difilippantonio et al., 2007; Stracker et al., 2007). While Stracker et al. reported 
defects in the intra-S-phase checkpoint; Difilippantonio et al. did not observe cell cycle 
checkpoint defects at any stage. Both groups observed abrogated apoptotic signaling 
through Atm in the thymus, but Difilippantonio et al. reported normal apoptotic induction 
in the nervous system of Nbs1
!C/!C
 mutants. Thus, the connection between the Nbs1-Atm 
interaction and Atm signaling in the brain remains somewhat obscure. The conditionally 
null Nbs1 mutant Nbn
f6/f6
 mice support this conclusion, as p53-dependent apoptosis is a 
major contributor to the microcephaly and neurogenesis defects reported in this animal 
model (Frappart et al., 2005). Interestingly, NBS and ATR-Seckel syndrome share more 
similarities than do NBS and A-T. As already alluded to in Chapter 3, the Nbn
f6/f6
 (also 
on a Nestin-cre background) and Atr
Nes-cre
 mice have strikingly similar phenotypes that 
feature cerebellar dysgenesis and p53 stabilization. Unlike the Atr
Nes-cre
 phenotype 
however, p53 deficiency largely corrected the aberrant neurogenesis of Nbn
f6/f6 
mice, 
suggesting that p53-dependant apoptosis was the major factor in microcephaly (Frappart 
et al., 2005). Based upon our data and that reported in the Nbn
f6/f6
, we predict 
microcephaly associated with NBS to be the direct result of unrepaired DNA DSBs that 
result in p53-dependant apoptosis. Through treatment of neural stem cells isolated from 
Nbn
f6/f6 
pups with the Atm-inhibitor caffeine, Frappart et al. also provided some evidence 
that Atm was responsible for p53 induction. However, there is currently no report of 
Nbn
f6/f6
 Atm
-/-
 mice to confirm that to be the case. 
 
 While the link to p53 signaling after DNA damage in the phenotypes of Atm
-/-
, 
Mre11
ATLD1/ATLD1
, Nbs1
!B/!B
, and Lig4-deficient mice is clear, the signaling pathway that 
accounts for the Atr
Nes-cre
 phenotype remains to be determined. Despite the large amount 
of p53-dependant apoptosis observed in proliferating regions of the Atr
Nes-cre
 brain, p53 
loss did not affect the overall phenotype. This indicates that p53-dependent apoptosis is 
only a minor consequence of Atr loss, and that p53 induction is not a major function of 
ATR in the nervous system. Though phosphorylation of p53-serine 18 was blocked in the 
Atr
Nes-cre 
Atm
Nes-cre
 animals, total p53 induction was unaffected and apoptosis was not 
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dramatically attenuated. These results imply that Atm signaling through p53 was 
responsible for the elimination of only a small subset of Atr
Nes-cre
 cells, and that Atr and 
Atm signaling appear independent though somewhat cooperative in the nervous system. 
Indeed, it has been demonstrated using the Xrcc2
-/-
 animals in which p53-dependent 
apoptosis occurs in proliferating cells of the developing nervous system that Atm does 
not contribute to apoptosis resulting from HR inactivation (Orii et al., 2006). It was 
speculated that Atr might be the kinase responsible for stabilizing p53 in proliferating 
neural precursors, but that seems less likely to be the case in light of these data.  
 
 The half-life of p53 is reportedly only 10-30 minutes and many factors contribute 
to activation and stability of the protein (Culmsee & Mattson, 2005; DeLeo et al., 1979). 
The major events involved in p53 stabilization include phosphorylation, acetylation, 
interaction with MDM2, and proteasome inhibition. Numerous phosphorylation sites 
have been identified as contributing to p53 stabilization and activity (Culmsee & 
Mattson, 2005). In addition to p53-serine 18, another such site is serine 23 (the human 
homologue is p53-serine 20), which has been linked to the apoptotic function of p53. 
Studies in mice carrying p53 serine 18/23 to alanine mutations indicate that p53-
phosphoserine 18 is only partially required for DNA damage induced apoptosis. While 
p53
S18/23A
 mutant mice completely rescued neural apoptosis and embryonic lethality in the 
Xrcc4
-/-
 genetic background, mice carrying only the S18A mutation barely impacted the 
Xrcc4
-/-
 phenotype (Chao et al., 2006). Because the p53
S18/23A
 mutants showed much less 
apoptotic induction than either p53
S18A
 or p53
S23A
 mutants, it can be concluded that 
phosphorylation of both serine 18 and serine 23 synergistically optimize p53-dependent 
apoptosis in proliferating cells (Chao et al., 2003; Chao et al., 2006; MacPherson et al., 
2004). One report indicates that neither ATM nor ATR phosphorylate p53 on serine 20, 
which would be consistent with the presence of ATM/ATR-independent, p53-dependent 
apoptosis observed in the Atr
Nes-cre
 Atm
Nes-cre
 mice (Chehab et al., 1999). However, p53-
serine 23 is a target of Chk2 (Chehab et al., 2000). Chk2 hyperphosphorylation is 
severely abrogated in Atm
-/-
 cells (Ahn et al., 2000; Falck et al., 2001; Melchionna et al., 
2000). After IR, the Atm
-/-
 thymus exhibits approximately half the number of viable cells 
as does the p53
-/-
 thymus. However, Atm
-/-
 Chk2
-/-
 mice exhibit a similar amount of viable 
cells as the p53
-/-
 mice in the irradiated thymus (Stracker et al., 2007). Similarly, IR-
induced apoptosis was further abrogated in Mre11
ATLD1/ATLD1
 Chk2
-/-
 and Nbs1
!B/!B
 Chk2
-/-
 
thymocytes (Stracker et al., 2008; Stracker & Petrini, 2008). This suggests that Chk2 
mediation of p53-induced apoptosis is only partially dependent upon Atm. The level of 
p53-phosphoserine 20 has not been examined in the Atr
Nes-cre
 mice, but IR-induced 
phosphorylation of Chk2 is consistent with levels observed in Atr
Ctrl
 embryonic brains 
and in cultured neural stem cells (data not shown). Thus, it is necessary to perform 
western blot analysis of Chk2 phosphorylation to begin determining the signaling 
mechanism behind p53 stabilization in the developing Atr
Nes-cre
Atm
Nes-cre
 brains. 
 
 Though Atr-/Atm-independent Chk2 activity is a highly compelling candidate for 
induction of p53 in the Atr
Nes-cre
Atm
Nes-cre
 nervous system, there are other molecules that 
could also be responsible. As already alluded to in Chapter 3, p63 and p73 are also 
implicated in IR-induced activation of p53 in the embryonic brain (Flores et al., 2002). 
The potential roles of Atr and Atm signaling in mediation of p63/p73-induced p53 
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activity have not been explored. ARF signaling is another possible mechanism by which 
p53 stabilization might occur in Atr
Nes-cre 
Atm
Nes-cre
 embryos. The murine Ink4a locus 
encodes the tumor suppressor p19
Arf
, which induces cell cycle arrest through up-
regulation of p53 expression (Kamijo et al., 1997; Quelle et al., 1995). In Atm
-/-
 MEFs, 
p19
ARF
 deficiency reversed premature replicative senescence though Atm
-/-
 ARF
-/-
 mice 
retained radiation sensitivity and lymphoma latency was unchanged (Kamijo et al., 1999). 
Signaling through p19
Arf
 could thus be responsible for the proliferation defects observed 
in the Atr
Nes-cre
 nervous system, but if that was the case, then the p53
-/-
 background should 
have had a more positive effect upon neurogenesis defects in the Atr
Nes-cre 
mice. Indeed, 
Atr
Nes-cre
 mice were crossed onto an Ink4a/ARF mutant background, with no dramatic 
effect upon viability or brain morphology (data not shown). Embryonic studies have not 
yet been performed on these double mutants to ascertain the effects of Ink4a/ARF loss on 
p53 induction. Regardless of the signaling mechanisms behind p53 induction in the 
Atr
Nes-cre 
Atm
Nes-cre
 mice, it is clear that neither p53-dependent cell cycle arrest nor 
apoptosis are significantly responsible for the neurogenesis defects observed in the Atr
Nes-
cre
 mutants. This drastically separates the ATR-Seckel syndrome phenotype from the 
phenotypes of A-T, ATLD, NBS, and LIG4 syndrome in which p53 signaling is 
paramount. 
 
 
4.2 The Impact of DNA Damage Signaling upon Cell Cycle 
Regulation in Neural Progenitor Cells 
 
 While the role of ATM appears to be restricted to post-mitotic cells during 
neurogenesis, ATR and MRN are required to ensure replication of neural progenitor cell 
populations. The Lig4/Xrcc4 complex is critical to the NHEJ repair pathway, which is the 
primary mechanism through which DSBs are repaired in post-mitotic neurons. 
Deficiency of either Lig4 or Xrrc4 leads to DNA damage accumulation and Atm/p53-
dependent apoptosis in post-mitotic cells during neurogenesis (Frank et al., 2000; Gao et 
al., 2000; Lee et al., 2000). Xrcc2 is essential for the HR repair pathway, which is 
preferred in replicating cells and germline inactivation of Xrcc2 results in embryonic 
lethality and neural apoptosis (Deans et al., 2000). In contrast to findings in Lig4-
deficient mice, Xrcc2
-/-
 animals showed p53-dependent apoptosis in proliferating regions 
of the embryonic nervous system that was not Atm-dependent (Orii et al., 2006). This 
provided further indication that Atm is primarily involved in initiating apoptosis via p53 
in post-mitotic cells during neurogenesis. In unpublished data (not shown) The 
Mre11
ATLD1/ATLD1
 genetic background had no affect upon apoptosis in the embryonic 
Xrcc2
-/-
 nervous system, similar to the Atm
-/-
 background (Personal communication with 
Dr. Youngsoo Lee, March 6, 2009). However, the Nbs1
!B/!B
 background reduced Xrcc2
-/-
 
viability from the median age of E13.5 to E9.5, suggesting that Nbs1 has a potential role 
in HR (Personal communication with Dr. Youngsoo Lee, March 6, 2009). A role for 
Nbs1 function in ensuring replication fidelity through mediation of DNA repair is also 
implicated by the Nbn
f6/f6
; Nestin-cre mutant mouse. In addition to apoptosis, 
proliferation was decreased in the cerebellar EGL of these mice, as indicated by BrdU 
labeling experiments (Frappart et al., 2005). However, it was not indicated in that report 
if this replication defect was related to p53-induced cell cycle checkpoint activation (in 
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other words, was it rescued by p53 deficiency or was it p53-independent, as the 
proliferation decrease in the Atr
Nes-cre
 mutant seems to be?). Furthermore, the early 
embryonic lethality around E7.5 observed in Nbs
-/-
 mice is sufficient to indicate that Nbs1 
is required for HR (Zhu et al., 2001).  
 
 Similarly, conditional deletion of Mre11 in mouse embryonic stem cells revealed 
its requirement for proliferation (Xiao & Weaver, 1997). Mre11 nuclease activity (which 
is retained in the Mre11
ATLD1/ATLD1
 mutant) has recently been implicated in HR repair as 
well as in contributing to ATR activation, both of which would be consistent with early 
embryonic lethality. Mre11
H129N/H129N
 mutant mice are embryonic lethal by E10.5 due to 
overall failure to develop normally, it was particularly noted that there was no evidence 
of heart development. Loss of p53 did not impact viability. MEFs derived from a 
conditional allele showed decreased proliferation and genomic instability. Though this 
mutation did not affect ATM activity, it did confer hypersensitivity to IR and replication 
stress, consistent with decreased ATR activity that was indicated by very attenuated 
phosphorylation of Chk1 on serine 345 in Mre11
H129N/H129N 
cells (Buis et al., 2008). Thus, 
the MRN complex has been linked in vivo to ATR and ATM signaling. 
 
There is evidence that in addition to its interactions with ATM, the MRN complex 
is required for maintaining replication fidelity through association with ATR. Nbs1 
activity has been implicated both upstream and downstream of ATR signaling. Nbs1 is 
phosphorylated on serine 343 by ATR, in response to stalled replication forks (Olson et 
al., 2007a). Hyperphosphorylation of RPA in response to hydroxyurea treatment requires 
ATR, but phosphorylated Nbs1 is required for this activity independently of ATM 
activity (Manthey et al., 2007). It has also been shown that the MRN complex interacts 
with ATRIP, a factor required for ATR activation, through the FHA/BRCT domains of 
Nbs1 (Olson et al., 2007a). Interaction of the MRN complex with RPA also occurs 
through the Mre11 C-terminus and is CDK-dependent (Olson et al., 2007b). Nbs1 
reportedly interacts physically with TopBP1, which is involved in ATR activation 
through association with ATRIP, and its expression is reportedly decreased in Nbs1-
deficient cells (Mordes et al., 2008; Morishima et al., 2007). Consistent with 
requirements for Nbs1 upstream of ATR signaling, NBS cells reportedly show 
diminished phosphorylation of ATR targeted regions on Chk1, c-Jun, and p53 in response 
to either UV-irradiation or hydroxyurea treatment (Stiff et al., 2005). Another potential 
connection between ATR activity and MRN exists through the CtIP protein. The yeast 
homologue to human CtIP is Ctp1, which is required for efficient formation of RPA-
coated ssDNA adjacent to DSB sites (Limbo et al., 2007). Human CtIP is recruited to 
DSB sites exclusively during S/G1 phases and interacts with the MRN complex. CtIP is 
required for DSB end resection and thus for RPA and ATR recruitment to the break site 
(Sartori et al., 2007). Though more work is required to firmly establish the relationship 
between the MRN complex and ATR, it is a very compelling notion that these molecules 
are functionally entwined, particularly in light of their common developmental 
requirements and the similar consequences of hypomorphic mutations associated with 
NBS and ATR-SS.  
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 ATR signaling through claspin/Chk1 is critical to both the DNA damage response 
and controlling replication (Cimprich & Cortez, 2008). Through Rad17 modulation, 
claspin acts as an adaptor molecule at the replication fork to facilitate the ATR-Chk1 
interaction, following TopBP1-ATRIP mediated ATR activation (Cimprich & Cortez, 
2008; Kumagai & Dunphy, 2000; Liu et al., 2006; Shiotani & Zou, 2009; Wang et al., 
2006). Once activated by ATR, Chk1 is released from chromatin and free to 
phosphorylate its own substrates such as the CDC25 phosphatases, which regulate cell 
cycle progression (Cimprich & Cortez, 2008; Smits et al., 2006). The human genome 
contains 3 CDC25 genes, each of which is subject to alternative splicing. The CDC25 
phosphatases regulate cell cycle transitions through dephosphorylating and thereby 
activating cyclin dependent kinases (CDKs). All three isoforms (CDC25 A-C) are 
involved in regulating the G1-S and G2-M transitions, as well as mitosis. During S-phase, 
the inactivation of CDC25A is mediated by DNA damage-induced Chk1 and Chk2 
activity. G1 arrest is induced in response to DNA damage when Chk1 phosphorylates 
CDC25A, which results in its degradation and subsequent G2 arrest. In response to IR, 
Chk1 and Chk2 phosphorylate CDC25C, which prevents its interaction with CDK1-
cyclin B. CDC25B is also reportedly phosphorylated by Chk1, resulting in G2/M arrest. 
In addition to ATM/ATR mediated CDC25 phosphorylation, p38 also regulates 
checkpoint activation through CDC25 phosphorylation (Boutros et al., 2006).  
 
 The impact of ATR and ATM inactivation upon CDC25 and subsequent cyclin 
mediation has not been thoroughly characterized in the nervous system. Cells isolated 
from individuals with either ATR-SS or primary microcephaly caused by mutations in the 
microcephalin/BRIT1 gene (MCPH1) showed reduced CDC15A degradation associated 
with failure to activate the G2/M checkpoint, increased percentage of cells showing 
nuclear fragmentation, and an increased number of cells exhibiting supernumerary 
mitotic centrosomes in response to DNA damage (Alderton et al., 2006). Chk2 is a major 
ATM substrate, and in vitro ATM-deficiency results in G1-S and G2-M checkpoint 
failure, as well as early cellular senescence attributed to decreased p53 and Chk2 activity 
(Lavin, 2008). In the case of ATR and Nbs1 function in the nervous system, we can 
speculate that decreased cell cycle checkpoint activation results in aberrant replication 
followed by senescence or apoptosis of cells that have incurred genotoxic levels of DNA 
damage, hence the observations of apoptosis and decreased proliferation observed in the 
developing brains of Atr
Nes-cre
 and Nbn
f6/f6
 mutant mice (Frappart et al., 2005). Despite the 
observations of cell cycle checkpoint defects and early senescence in cells cultured from 
ATM deficient humans and mice, as well as from ATLD individuals and the 
Mre11
ATLD1/ATLD1
 mutant animals, the data presented here provides no indication that 
either inactivating ATM mutations or the hypomorphic mutations associated with ATLD 
have any impact upon cell cycle checkpoint integrity or proliferation in the nervous 
system (Lavin, 2008; Stewart et al., 1999; Taylor et al., 2004; Theunissen et al., 2003).  
 
 
4.3 Concluding Remarks 
 
 ATM, ATR, and the MRN complex are integral components of the DNA DSB 
signaling machinery. Autosomal recessive genetic mutations in ATM, ATR, Mre11, and 
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Nbs1 have been linked to diseases that share many characteristics such as cell cycle 
checkpoint deficiencies in cell lines such as fibroblasts, immunodeficiency, increased 
radiation sensitivity, and genomic instability. Inactivating, autosomal recessive mutations 
in ATM are responsible for ataxia-telangiectasia, which is characterized by 
neurodegeneration and consequent ataxia, cancer proneness, ocular telangiectasias, 
increased !-fetoprotein levels, and immunodeficiency (OMIM #208900). Hypomorphic 
mutations in ATR have been identified in a subset of individuals diagnosed with Seckel 
syndrome (OMIM #601215). Seckel syndrome presents with intrauterine growth defects, 
microcephaly, dwarfism, and variable degrees of mental retardation (OMIM #210600). 
ATR-Seckel syndrome individuals present with these characteristics as well as the above 
mentioned hallmarks of genomic instability. ATM and ATR are similar PIKKs that 
divide the DNA DSB response between signal transduction of DSBs induced by sources 
such as IR and DSBs that result from replication stress, respectively. The MRN complex 
is implicated in modulating the activity of both molecules and in directly facilitating DSB 
repair through tethering of broken ends and 5’-3’ resection (Cimprich & Cortez, 2008; 
McKinnon, 2009). Hypomorphic mutations in its components Mre11 and Nbs1 result in 
ataxia-telangiectasia-like disease (OMIM #604391) and Nijmegen breakage syndrome 
(OMIM #251260), respectively. ATLD differs from A-T in the absence of telangiectasia 
and increased !-fetoprotein levels, but presents with very similar neurodegeneration and 
ataxia, but with longer latency. NBS shares many characteristics with ATR-SS, 
particularly microcephaly. 
 
This work has sought to delineate the signaling mechanisms that account for the 
distinct neuropathology observed in these individual genetic deficiencies using mouse 
models. While Atm
-/-
 and Mre11
ATLD1/ATLD1
 mice show abrogated p53-dependent apoptotic 
induction in post-mitotic regions of the developing brain, Nbs1
!B/!B
 animals showed 
normal levels of cell death in response to DNA DSBs despite reduced Atm activity. This 
data indicates that while reduced elimination of cells harboring DNA damage is involved 
in the pathology of A-T and ATLD, the microcephaly associated with NBS is likely 
attributable to increased Atm/p53-dependent cell death as a result of DNA repair 
deficiency. In terms of Atm signaling in response to DSBs, these results indicate that 
there is an as yet undefined threshold of Atm activity required to efficiently induce 
apoptosis and that the Nbs1
!B/!B
 mutation does not suppress Atm function to the same 
extent that the ATLD mutation does, thus producing different neurologic consequences 
when challenged by DNA damage (Shull et al., 2009). By comparing the neuropathology 
and neural DNA damage response of Atr
Nes-cre
 and Atr
Nes-cre
 Atm
Nes-cre 
mice, we have 
reiterated that Atm is not significantly involved in the DNA damage response of 
replicating neural precursors and Atr deficiency results in microcephaly and neurogenesis 
defects through a combination of apoptosis and decreased proliferation of neural 
precursor cells associated with increased DNA damage in proliferating regions of the 
developing brain. While apoptotic signaling proved to be p53-dependent and Atm-
independent, the signaling mechanisms behind the proliferation defect in the Atr
Nes-cre
 
brain have yet to be identified. Overall, the data presented here provides valuable insights 
into the tissue-specific requirements of ATM, ATR, and MRN signaling and sheds new 
light onto the etiology of the neurologic phenotypes resulting from deficiency of these 
molecules. 
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